Language selection

Search

Patent 2740663 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 2740663
(54) English Title: PRODUCTION AND USE OF METHIONYLMETHIONINE AS FEED ADDITIVE FOR FISH AND CRUSTACEANS
(54) French Title: PREPARATION ET UTILISATION DE METHIONYLMETHIONINE EN TANT QU'ADDITIF AUX PRODUITS D'ALIMENTATION ANIMALE, POUR DES POISSONS ET DES CRUSTACES
Status: Deemed expired
Bibliographic Data
(51) International Patent Classification (IPC):
  • A23K 50/80 (2016.01)
  • A23K 20/10 (2016.01)
  • A23K 20/142 (2016.01)
  • C07K 1/00 (2006.01)
  • C07K 5/062 (2006.01)
(72) Inventors :
  • KOBLER, CHRISTOPH (Germany)
  • HAEUSSNER, THOMAS (Germany)
  • WECKBECKER, CHRISTOPH (Germany)
(73) Owners :
  • EVONIK OPERATIONS GMBH (Germany)
(71) Applicants :
  • EVONIK DEGUSSA GMBH (Germany)
(74) Agent: MARKS & CLERK
(74) Associate agent:
(45) Issued: 2017-01-17
(86) PCT Filing Date: 2009-10-09
(87) Open to Public Inspection: 2010-04-22
Examination requested: 2014-10-06
Availability of licence: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): Yes
(86) PCT Filing Number: PCT/EP2009/063160
(87) International Publication Number: WO2010/043558
(85) National Entry: 2011-04-14

(30) Application Priority Data:
Application No. Country/Territory Date
10 2008 042 932.5 Germany 2008-10-17

Abstracts

English Abstract



The invention relates to the use of
DL-methionyl-DL-methionine and salts thereof as a feed additive
in feed mixtures for animals held in aquacultures, and a
method for producing DL-methionyl-DL-methionine (I)
having the formula (I) by converting a urea derivative of the
general formula (II) to DL-methionyl-DL-methionine,
wherein the groups R1 and R2 in the urea derivatives IIa, IIb,
IIc, IId, IIe, IIf, and IIg are defined as follows: IIa: R1 =
COOH, R2 = NHCONH2 IIb: R1 = CONH2, R2 = NHCON-
H2 IIc: R1 = CONH2, R2 = NH2 IId: R1 -R2 =-CONH-
CONH-IIe: R1=CN,R2 =OH IIf:R1=CN,R2=NH2 IIg:
R1= =O, R2 = H.




French Abstract

L'invention porte sur l'utilisation de DL-méthionyl-DL-méthionine et de ses sels, en tant qu'additif pour produits d'alimentation animale, dans des mélanges de produits d'alimentation animale destinés à des animaux élevés en aquaculture, ainsi que sur un procédé de préparation de DL-méthionyl-DL-méthionine (I) de formule (I) par transformation d'un dérivé d'urée représenté par la formule générale (II) en la DL-méthionyl-DL-méthionine, les radicaux R1 et R2 des dérivés d'urée IIa, IIb, IIc, IId, IIe, IIf et IIg étant définis comme suit : IIa : R1 = COOH, R2 = NHCONH2; IIb : R1 = CONH2, R2 = NHCONH2; IIc : R1 = CONH2, R2 = NH2; IId : R1 -R2 = -CONHCONH-; IIe : R1 = CN, R2 = OH; IIf : R1 = CN, R2 = NH2; IIg : R1= =O, R2 = H.

Claims

Note: Claims are shown in the official language in which they were submitted.


55
The embodiments of the invention in which an exclusive
property or privilege is claimed are defined as follows:
1. Use of DL-methionyl-DL-methionine or a salt thereof as a
feed additive in a feed mixture for animals kept in
aquaculture.
2. The use as claimed in claim 1, wherein the salt is a
cation which is an alkali metal, an alkaline earth
metal, ammonium, Cu2+, Zn2"' or Co2+.
3. The use as claimed in claim 1 or 2, wherein the feed
mixture comprises from 0.01 to 5%.by weight of
DL-methionyl-DL-methionine.
4. The use as claimed in claim 1 or 2, wherein the feed
mixture comprises from 0.05 to 0.5% by weight of DL-
methionyl-DL-methionine.
5. The use as claimed in any one of claims 1 to 4, wherein
the feed mixture comprises protein and carbohydrates, and
optionally is supplemented with essential amino acids, proteins,
peptides, vitamins, minerals, carbohydrates, fats or oils, or
any combination thereof.
6. The use as claimed in any one of claims 1 to 4, wherein
the feed mixture is based on fish meal, soybean meal or corn
meal, and optionally is supplemented with essential amino acids,
proteins, peptides, vitamins, minerals, carbohydrates, fats or
oils, or any combination thereof.
7. The use as claimed in any one of claims 1 to 6, wherein
DL-methionyl-DL-methionine is present alone or as a salt as a
DD/LL/LD/DL mixture, as a DL/LD or a DD/LL mixture, optionally
in each case additionally mixed with DL-methionine.

56
8. The use as claimed in claim 7, wherein the DL-methionine
content is from 0.01 to 20% by weight.
9. The use as claimed in claim 7, wherein the DL-methionine
content is from 1 to 10% by weight.
10. The use as claimed in any one of claims 1 to 9, wherein
DL-methionyl-DL-methionine is present as a DL/LD-
methionylmethionine pair of enantiomers.
11. The use as claimed in any one of claims 1 to 10,
wherein the animals kept in aquaculture are salt or fresh
water fish or crustaceans.
12. The use as claimed in any one of claims 1 to 10,
wherein the animals kept in aquaculture are carp, trout,
salmon, catfish, perch, flatfish, sturgeon, tuna, eels,
bream, cod, shrimps, krill or prawns.
13. The use as claimed in any one of claims 1 to 10, wherein
the animals kept in aquaculture are silver carp
(Hypophthalmichthys molitix), grass carp (Ctenopharyngodon
idella), common carp (Cyprinus carpio), bighead carp
(Aristichthys nobilis), carassius (Carassius carassius), catla
(Catla Catla), Roho labeo (Labeo rohita) , Pacific or Atlantic
salmon (Salmon salar or Oncorhynchus kisutch), rainbow trout
(Oncorhynchus mykiss), American catfish (Ictalurus punctatus),
African catfish (Clarias gariepinus), pangasius (Pdngasius
bocourti or Pangasius hypothalamus), Nilc tilapia (Oreochromis
niloticus), milkfish (Chanos chanos), cobia (Rachycentron
canadum), whiteleg shrimp (Litopenaeus vannamei), black tiger
shrimp (Penaeus monodon) or giant river prawn (lacrobrachium
rosenbergii).

57
14. A process for preparing DL-methionyl-DL-methionine of
the formula (I)
Image
(I)
by reacting a urea derivative of the general formula (II)
<MG>
(II)
where the radicals R1 and R2 in the urea derivatives IIa, IIb,
IIc, Ile and IIf are defined as follows:
where IIa: R1 COOH, R2 = NHCONH2
IIb: R1 = CONH2, R2 = NHCONH2
IIc: R1 = CONH2, R2 - NH2
Ile: R1 = CN, R2 OH
IIf: R1 = CN, R2 - NH2
to give DL-methionyl-DL-methionine.
15. The process as claimed in claim 14, wherein the pH of
the solution comprising the urea derivative is adjusted to
from 8 to 14.

58
16. The process as claimed in claim 14, wherein the pH of
the solution comprising the urea derivative is adjusted to
from 10 to 13.
17. The process as claimed in any one of claims 14 to 16,
wherein the reaction takes place at a temperature of from 50
to 200°C.
18. The process as claimed in any one of claims 14 to 16,
wherein the reaction takes place at a temperature of from 80
to 170°C.
19. The process as claimed in any one of claims 14 to 16,
wherein the reaction takes place at a temperature of from 130 to
160°C.
20. The process as claimed in any one of claims 14 to 19,
wherein the reaction is carried out under pressure.
21. The process as claimed in any one of claims 14 to 19,
wherein the reaction is carried out under a pressure of from 3
to 20 bar.
22. The process as claimed in any one of claims 14 to 19,
wherein the reaction is carried out under a pressure of from 6
to 15 bar.
23. The process as claimed in claim 14, comprising the
following steps:
a) reaction of the urea derivative of formulae IIa, IIb,
IIc, Ile and IIf to give a diketopiperazine of the formula
(III)

59
Image
(III)
b)
reaction of the diketopiperazine (III)to give DL-methionyl-
DL-methionine (I).
24. The process as claimed in claim 23, wherein the
reaction of the urea derlvative to give the diketopiperazine
is carried out at a temperature of from 50°C to 200°C.
25. The process as claimed in claim 23, wherein the
reaction of the urea derivative to give the diketopiperazine
is carried out at a temperature of from 100°C to 180°C.
26. The process as claimed in claim 23, wherein the
reaction of the urea derivative to give the diketopiperazine
is carried out at a temperature of from 140°C to 170°C.
27. The process as claimed in any one of claims 23 to 26,
wherein the reaction of the urea derivative to give the
diketopiperazine is carried out under pressure.
28. The process as claimed in any one of claims 23 to 26,
wherein the reaction of the urea derivative to give the
diketopiperazine is carried out under a pressure of from 3 to 20
bar.
29. The process claimed in any one of claims 23 to 26, wherein

60
the reaction of the urea derivative to give the diketopiperazine
is carried out under a pressure of from 6 to 15 bar.
30. The process as claimed in any one of claims 23 to 29,
wherein the reaction of the urea derivative to give the
diketopiperazine takes place in the presence of a base.
31. The process as claimed in claim 30, wherein the base is a
nitrogen-containing base, NH4HC03, (NH4)2C02, KHC02, K2C03,
NH40H/C02 mixture, a carbamate salt, an alkali metal or alkaline
earth metal base.
32. The process as claimed in any one of claims 23 to 31,
wherein the reaction of the urea derivative to give the
diketopiperazine takes place by reaction with methionine.
33. The process as claimed in any one of claims 23 to 32,
wherein the reaction of the diketopiperazine to give DL-
methionyl-DL-methionine takes place by acidic hydrolysis.
34. The process as claimed in claim 33, wherein the acidic
hydrolysis takes place in the presence of an acid which is a
mineral acid, HCl, E2C03, C02 /H20, H2S04, a phosphoric acid, a
carboxylic acid or a hydroxy carboxylic acid.
35. The process as claimed in any one of claims 23 to 32,
wherein the reaction of the diketopiperazine to give DL-
methionyl-DL-methionine takes place by basic hydrolysis.
36. The process as claimed in claim 35, wherein the basic
hydrolysis is carried out at a pH of from 7 to 14 in order to
obtain DL-methionyl-DL-methionine.
37. The process as claimed in claim 35, wherein the basic
hydrolysis is carried out at a pH of from 9 to 12 in order to
obtain DL-methionyl-DL-methionine.

61
38. The process as claimed in claim 35, wherein the basic
hydrolysis is carried out at a pH of from 10 to 11 in order to
obtain DL-methionyl-DL-methionine.
39. The process as claimed in any one of claims 35 to 38,
wherein the basic conditions are adjusted by using a substance
which is a nitrogen-containing base, NH4HC03, (NH4)2C03, NH40H/C02
mixture, a carbamate salt, KHC03, K2C03, a carbonate, an alkali
metal base or an alkaline earth metal base.
40. The process as claimed in any one of claims 33 to 39,
wherein the reaction is carried out at a temperature of from
50°C to 200°C.
41. The process as claimed in any one of claims 33 to 39,
wherein the reaction is carried out at a temperature of from
80°C to 180°C.
42. The process as claimed in any one of claims 33 to 39,
wherein the reaction is carried out at a temperature of from
90°C to 160°C.
43. The process as claimed in any one of claims 23 to 32,
wherein the reaction of the diketopiperazine to give DL-
methionyl-DL-methionine takes place by introducing CO2 into a
basic solution.
44. The process as claimed in any one of claims 23 to 32,
wherein the reaction of the diketopiperazine to give DL-
methionyl-DL-methionine takes place by introducing C02 into a
basic ammonium hydroxide, potassium hydroxide or sodium
hydroxide solution.
45. The process as claimed in any one of claims 23 to 44,
wherein the diketopiperazine is isolated before the

62
hydrolysis.
46. The process as claimed in claim 45, wherein the
diketopiperazine is isolated by crystallization from the
reaction solution.
47. The process as claimed in claim 45, wherein the
diketopiperazine is isolated by crystallization from the
reaction solution at a temperature of from -30 to
120°C.
48. The process as claimed in claim 45, wherein the
diketopiperazine is isolated by crystallization from the
reaction solution at a temperature of from 10 to 70°C.
49. A process for isolating a mixture of DD/LL/DL/LD-
methionylmethionine diastereomers by crystallization from a
basic reaction solution which has been obtained by a process as
defined in any one of claims 14 to 22 and 35 to 48.
50. The process as claimed in claim 49, wherein the solution
is adjusted with an acid to a pH of from 5 to 9.
51. The process as claimed in claim 49, wherein the solution
is adjusted with an acid to a pH of from 5 to 7.
52. The process as claimed in claim 49, wherein the solution is
adjusted with an acid to a pH of about 5.6.
53. The process as claimed in any one of claims 49 to 52,
wherein the crystallization takes place in the presence of an
acid which is a mineral acid, HCl, H2C03, C02/H20,H2S04, a
phosphoric acid, a carboxylic acid, or a hydroxy carboxylic
acid.
54. A process for isolating a mixture of DD/LL/DL/LD-

63
methionylmethionine diastereomers by crystallization from
acidic reaction solution obtained by a process as defined in
claim 33 or 34.
55. The process as claimed in claim 54, wherein the solution
is adjusted with a base to a pH of from 5 to 9.
56. The process as claimed in claim 54, wherein the solution
is adjusted with a base to a pH of from 5 to 7.
57. The process as claimed in claim 54, wherein the solution
is adjusted with a base to a pH of about 5.6.
58. The process as claimed in any one of claims 54 to 57,
wherein the base is NH4HC03, (NH4)2C03, a nitrogen-containing
base, NH40H, a carbamate salt, KHC03, K2C03, a carbonate, an
alkali metal or alkaline earth metal base.
59. The process as claimed in any one of claims 14 to 58,
wherein the process is carried out in an aqueous medium.

Description

Note: Descriptions are shown in the official language in which they were submitted.


WO 2010/043558 CA 02740663 2011-04-14
PCT/EP2009/063160
1
Production and use of methionylmethionine as feed additive
for fish and crustaceans
Introduction
The present invention relates to novel chemical syntheses
of methionylmethionine, the dipeptide of methionine, and
the specific use thereof as feed additive alone or mixed
with methionine for fish and crustacean nutrition.
Prior art
Essential amino acids (EAA) such as methionine, lysine or
threonine are very important constituents as feed additives
in animal nutrition and play a significant part in the
commercial rearing of productive animals such as, for
example, chickens, pigs and ruminants. Supplementation of
natural protein sources such as, for example, soybeans,
corn and wheat with EAAs makes it possible on the one hand
for the animals to grow faster, or for milk production to
be higher in high-output dairy cows, but on the other hand
for the utilization of the feed to be more efficient. This
represents a very great commercial advantage. The markets
for feed additives are of great industrial and commercial
importance. In addition, they are high-growth markets,
attributable not least to the increasing importance of
countries such as, for example, China and India.
L-Methionine ((S)-2-amino-4-methylthiobutyric acid)
represents the first limiting amino acid for many species
such as chickens, ducks, turkeys and also for many fish and
shellfish species and therefore plays a very significant
part in animal nutrition and as feed additive (Rosenberg et
al., J. Agr. Food Chem. 1957, 5, 694-700 and Lovell, T. R.,
J. Anim. Sci. 1991, 69, 4193-4200). However, in the

WO 2010/043558 CA 02740663 2011-04-14
PCT/EP2009/063160
2
classical chemical synthesis, methionine results as
racemate, a 50:50 mixture of D- and L-methionine. This
racemic DL-methionine can, however, be employed directly as
feed additive because there is in some species under in
vivo conditions a transformation mechanism which converts
the unnatural D enantiomer of methionine into the natural
L enantiomer. This entails firstly the D-methionine being
deaminated with the aid of a nonspecific D-oxidase to
a-ketomethionine, and subsequently being further
transformed with an L-transaminase into L-methionine
(Baker, D.H. in "Amino acids in farm animal nutrition",
D'Mello, J.P.F. (ed.), Wallingford (UK), CAB International,
1994, 37-61). The available amount of L-methionine in the
body is increased thereby and can then be available to the
animal for growth. The enzymatic transformation of D- to
L-methionine has been detected in chickens, pigs and cows,
but especially also in carnivorous and omnivorous fish and
also in shrimps and prawns. Thus, for example, Sveier et
al. (Aquacult. Nutr. 2001, 7 (3), 169-181) and Kim et al.
(Aquaculture 1992, 101 (1-2), 95-103) were able to show
that the transformation of D- into L-methionine is possible
in carnivorous Atlantic salmon and rainbow trout. Robinson
et al. (J. Nutr. 1978, 108 (12), 1932-1936) and Schwarz et
al. (Aquaculture 1998, 161, 121-129) were able to show the
same for omnivorous fish species such as, for example,
catfish and carp. In addition, Forster and Dominy (J. World
Aquacult. Soc. 2006, 37 (4), 474-480) were able to show in
feeding experiments on omnivorous shrimps of the species
Litopenaeus vanhamei that DL-methionine has the same
activity as L-methionine.
The world production in 2007 of crystalline DL-methionine
and racemic, liquid methionine hydroxy analog (MHA, rac-2-
hydroxy-4-(methylthio)butanoic acid (HMB)) and solid
calcium MHA was more than 700 000 t, which was successfully
employed directly as feed additive for monogastric animals
such as, for example, poultry and pigs. Owing to the rapid

WO 2010/043558 CA 02740663 2011-04-14
PCT/EP2009/063160
3
commercial development of fish and crustacean farming in
highly industrialized aquacultures an optimal, economical
and efficient methionine supplementation option has become
increasingly important precisely in this area in recent
years (Food and Agriculture Organization of the United
Nation (FAO) Fisheries Department "State of World
Aquaculture 2006", 2006, Rome, International Food Policy
Research Institute (IFPRI) "Fish 2020: Supply and Demand in
Changing Markets", 2003, Washington, D.C.). However, in
contrast to chickens and pigs, various problems occur on
use of methionine, MHA or Ca-MHA as feed additive for
certain fish and crustacean varieties. Thus, Rumsey and
Ketola (J. Fish. Res. Bd. Can. 1975, 32, 422-426) report
that the use of soybean meal in conjunction with singly
supplemented crystalline amino acids did not lead to any
increase in growth of rainbow trout. Mural et al. (Bull.
Japan. Soc. Sci. Fish. 1984, 50, (11), 1957) were able to
show that daily feeding of fish diets with high rates of
supplemented crystalline amino acids in carp led to more
than 40% of the free amino acids being excreted via the
gills and kidneys. Because of the rapid absorption of
supplemented amino acids shortly after feed intake, there
is a very rapid rise in the amino acid concentration in the
fish's blood plasma (fast response). However, at this time,
the other amino acids from the natural protein sources such
as, for example, soybean meal are not yet present in the
plasma, possibly leading to asynchronicity of the
concurrent availability of all the important amino acids.
As a result thereof, part of the highly concentrated amino
acids is rapidly excreted or rapidly metabolized in the
body, and is used for example as pure energy source. As a
result, there is only a slight or no increase in growth of,
upon use of crystalline amino acids as feed additives (Aoe
et al., Bull. Jap. Carp Soc. Sci. Fish. 1970, 36, 407-413).
Supplementation of crystalline amino acids may lead to
further problems in crustaceans. The slow feeding behavior
of certain crustaceans such as, for example, shrimps of the

WO 2010/043558 CA 02740663 2011-04-14
PCT/EP2009/063160
4
species Litopenaeus Vannamei results, owing to the long
residence time of the feed under water, in the
supplemented, water-soluble amino acids being dissolved out
(leaching), leading to eutrophication of the water and not
to an increase in growth of the animals (Alam et al.,
Aquaculture 2005, 248, 13-16).
Efficiently supplying fish and crustaceans kept in
aquacultures thus requires, for certain species and
applications, a specific methionine product form, such as,
for example, an appropriately chemically or physically
protected methionine. The aim of this is on the one hand
that the product remains sufficiently stable in the aqueous
environment during feeding and is not dissolved out of the
feed. On the other hand that the methionine product
eventually taken in by the animal can be utilized optimally
and with high efficiency in the animal body.
Many efforts have been made in the past to develop suitable
feed additives, particularly based on methionine, for fish
and crustaceans. Thus, for example, W08906497 describes the
use of di- and tripeptides as feed additive for fish and
crustaceans. The intention of this is to promote the growth
of the animals. However, the di- and tripeptides preferably
employed in this case were from nonessential and therefore
also nonlimiting amino acids such as, for example, glycine,
alanine and serine. The only methionine-containing
dipeptides described are DL-alanyl-DL-methionine and
DL-methionyl-DL-glycine. However, this means that
effectively only 50% of active substance (mol/mol) are
present in the dipeptide, and this must be categorized as
very disadvantageous from the aspect of economics.
W002088667 describes the enantioselective synthesis and use
of oligomers of MHA and amino acids such as, for example,
methionine as feed additives, inter alia also for fish and
crustaceans. It is said to be possible to achieve faster
growth thereby. The described oligomers are assembled by an

WO 2010/043558 CA 02740663 2011-04-14
PCT/EP2009/063160
enzyme-catalyzed reaction and exhibit a very broad
distribution of the chain lengths of the individual
oligomers. This makes the process unselective, costly and
elaborate in the procedure and purification. Dabrowski et
5 al. describes in US20030099689 the use of synthetic
peptides as feed additives for promoting the growth of
aquatic animals. In this case, the proportion of the
peptides in the complete feed formulation may be 6-50% by
weight. The synthetic peptides preferably consist of
essential and limiting amino acids. However, the synthesis
of such synthesized oligo- and polypeptides is very
elaborate, costly and difficult to convert to the
industrial scale. In addition, the effectiveness of
polypeptides of a single amino acid is disputed, because
these are often converted only very slowly or not at all
under physiological conditions into free amino acids. Thus,
for example, Baker et al. (J. Nutr. 1982, 112, 1130-1132)
describes the lack of biological value of poly-L-methionine
in chickens because of the absolute insolubility in water,
since absorption by the body is impossible.
Besides the use of novel chemical methionine derivatives
such as, for example, methionine-containing peptides and
oligomers, there has also been investigation of various
physical protection possibilities such as, for example,
coatings and the incorporation of an amino acid in a
protective matrix. Thus, for example, Alam et al.
(Aquacult. Nutr. 2004, 10, 309-316 and Aquaculture 2005,
248, 13-19) were able to show that coated methionine and
lysine has, in contrast to uncoated, a very positive
influence on the growth of young kuruma shrimps. Although
use of a specific coating was able to suppress the leaching
of methionine and lysine out of the feed pellet, there are
some serious disadvantages. The preparation or the coating
of methionine usually represents a technically complicated
and elaborate process and is therefore costly. In addition,
the surface coating of the methionine after coating is

WO 2010/043558 CA 02740663 2011-04-14
PCT/EP2009/063160
6
easily damaged by mechanical stress and abrasion during
feed processing, possibly leading to a diminution or
complete loss of the physical protection. An additional
factor is that the content of methionine is reduced, and
thus often becomes uneconomic, by a coating or use of a
matrix substance.
Besides the inventive novel use of DL-methionyl-DL-
methionine as feed additive with low leaching
characteristics from feed pellets and extrudates, and an
optimal supply of methionine to the body through slow-
release cleavage of methionylmethionine, it has also been
possible to develop novel processes for preparing
methionylmethionine which have many advantages over the
preparation variants described in the literature. Most of
the dipeptide syntheses disclosed in the literature use
costly protective groups such as, for example, Boc- (tert-
butoxycarbonyl) or Z-(benzyloxycarbonyl) protective groups,
which have to be attached to the appropriate amino acid
before the actual dipeptide synthesis, and subsequently
eliminated again. In addition, activation of the amino
acids to be coupled is usually necessary. Thus,
methionylmethionine can be prepared by coupling N-Boc-
methionine with the methyl ester of methionine using
dicyclohexylcarbodiimide (DCC). The great disadvantages of
this preparation process are the use of costly protective
groups, a very elaborate synthesis and costly coupling
reagents which cannot be recycled, such as, for example,
DCC. Another alternative for the industrial synthesis of
methionylmethionine is described in DE2261926. 3,6-Bis[2-
methylthio)ethy1]-2,5-piperazinedione (methioninediketo-
piperazine, DKP) is formed in the first stage by heating
the isopropyl ester of methionine and is then hydrolyzed to
methionylmethionine. Merely satisfactory yields of 62-65%
were possible for the hydrolysis step in this case. In
addition, the use of methionine isopropyl ester as starting
material is too costly and therefore uneconomic.

WO 2010/043558 CA 02740663 2011-04-14
PCT/EP2009/063160
7
Object of the invention
One general object was to provide a feedstuff or a feed
additive for animal nutrition based on a novel methionine
substitute which can be employed alone or as mixture with
methionine especially in the sector of industrial fish and
crustacean farming in aquacultures. It was intended at the
same time to develop a simple and cost-effective chemical
synthesis of this novel methionine substitute.
In the light of the prior art disadvantages, it was the
object in particular to provide a chemically protected
methionine product for various omnivorous, herbivorous and
carnivorous fish and crustacean species which live in salt
or fresh water. It was intended in particular that this
product show low solubility characteristics (leaching) from
the complete feed pellet or extrudate in water and possess
a slow-release mechanism, i.e. a slow and continuous
release of free methionine under physiological conditions.
In addition, it was also intended that the novel methionine
product can be employed advantageously as mixture with
DL-methionine.
A further object was to find a methionine substitute as
feedstuff or a feed additive which has very high biological
value and which was intended to be easy to handle and store
and have good stability under the usual conditions of
compound feed processing, especially pelleting and
extrusion.
It was intended in this way to provide the fish and
crustaceans with a further efficient methionine source,
besides crystalline DL-methionine, which source exhibits if
possible the disadvantages of the known products to only a
reduced extent or not at all.
It was further intended to develop a novel, flexible
synthesis route for methionylmethionine (DL-methionyl-DL-

WO 2010/043558
PCT/EP2009/063160
CA 02740663 2011-04-14
8
methionine) in which the typical precursors and byproducts
from the industrial DL-methionine production process can be
used as starting material. It was additionally intended to
develop a suitable process for separating the pairs of
diastereomers DD/LL- and DL/LD-methionylmethionine, so that
an optimal and efficient use of only one pair of
diastereomers (DL/LL-I or DL/LD-I) is possible for specific
applications.
Description of the invention
The object is achieved by the use of DL-methionyl-DL-
methionine and salts thereof as feed additive in feed
mixtures for animals kept in aquacultures.
In a preferred manner, the feed mixture comprises from 0.01
to 5% by weight, and preferably comprises from 0.05 to 0.5%
by weight of DL-methionyl-DL-methionine.
The use of DL-methionyl-DL-methionine has proved to be
particularly advantageous in this connection because the
compound shows excellent leaching characteristics because
of the low solubility of the mixture of DD/LL/DL/LD-
methionylmethionine and of the pair of diastereomers DL/LD-
methionylmethionine (0.4 g/l).
The compound further shows good pelleting and extrusion
stability during feed production. DL-Methionyl-DL-
methionine is stable in mixtures with conventional
components and feedstuffs such as, for example, cereals
(e.g. corn, wheat, triticale, barley, millet, inter alia),
vegetable or animal protein sources (e.g. soybeans and
oilseed rape and the products of the processing thereof,
legumes (e.g. peas, beans, lupins, etc.), fish meal, inter
alia) and in combination with supplemented essential amino
acids, proteins, peptides, carbohydrates, vitamins,
minerals, fats and oils.

WO 2010/043558
PCT/EP2009/063160
CA 02740663 2011-04-14
9
It is further advantageous that, one mole of water is saved
per mole of methionylmethionine compared with DL-methionine
owing to the high active substance content of
methionylmethionine per kg of substance.
In a preferred use, the feed mixture comprises proteins and
carbohydrates, preferably based on fish meal, soybean meal
or corn meal, and may be supplemented with essential amino
acids, proteins, peptides, vitamins, minerals,
carbohydrates, fats and oils.
It is particularly preferred for the DL-methionyl-DL-
methionine to be present in the feed mixture solely as
DD/LL/LD/DL mixture, as DL/LD or DD/LL mixture, preferably
in each case additionally mixed with DL-methionine,
preferably with a DL-methionine content of from 0.01 to 20%
by weight, particularly preferably of from 1 to 10% by
weight.
In a particularly preferred use, DL-methionyl-DL-methionine
is present as a DL/LD-methionylmethionine pair of
enantiomers.
In a preferred use, the animals kept in aquacultures are
fresh and salt water fish and crustaceans selected from the
group consisting of carp, trout, salmon, catfish, perch,
flatfish, sturgeon, tuna, eels, bream, cod, shrimps, krill
and prawns, very preferably for silver carp
(Hypophthalmichthys molitrix), grass carp (Ctenopharyngodon
idella), common carp (Cyprinus carpio) and bighead carp
(Aristichthys nobilis), carassius (Carassius carassius),
catla (Catla Catla), Roho labeo (Labeo rohita), Pacific and
Atlantic salmon (Salmon salar and Oncorhynchus kisutch),
rainbow trout (Oncorhynchus mykiss), American catfish
(Ictalurus punctatus), African catfish (Clarias
gariepinus), pangasius (Pangasius bocourti and Pangasius
hypothalamus), Nile tilapia (Oreochromis niloticus),
milkfish (Chanos), cobia (Rachycentron canadum), whiteleg

WO 2010/043558
PCT/EP2009/063160
CA 02740663 2011-04-14
shrimp (Litopenaeus vannamei), black tiger shrimp (Penaeus
monodon) and giant river prawn (Macrobrachium rosenbergii).
According to the invention, DL-methionyl-DL-methionine (I)
(methionylmethionine or Met-Met for short) or its alkali
5 metal and alkaline earth metal salts such as, for example,
the slightly soluble calcium or zinc salt is used as
addition in feed mixtures as DD/LL/DL/LD, DD/LL or DL/LD
diastereomer mixture, alone or mixed with DL-methionine,
preferably for fish and crustaceans:
10 0
NH2
SCO2H
(I)
Four different stereoisomers (diastereomers) exist of the
dipeptide DL-methionyl-DL-methionine (I), DD-, LL, DL- and
LD-I, of which only L-methionyl-L-methionine (LL-I) is
natural, all the other three dipeptides L-methionyl-D-
methionine (LD-I), D-methionyl-L-methionine (DL-I) and
D-methionyl-D-methionine (DD-I) being unnatural (see
scheme 1).

WO 2010/043558 CA 02740663 2011-04-14 PCT/EP2009/063160
11
0
HN1)r'7S' HN
NH2 NH2
\CO21
CO2H
(DD-I) (LL-I)
HU HN
NH2 l\lH2
\
CO2H CO2H
(DL-I) (LD-I)
Scheme 1
In this connection, DD-I and LL-I are related to one
another as image and mirror image, i.e. they are
enantiomers and thus have the same physical properties. The
same applies to the DL-I and LD-I pair.
The two pairs DD/LL-I and DL/LD-I are by contrast
diastereomers of one another, i.e. they have different
physical data. Thus, for example, the DD/LL-I pair of
diastereomers has a solubility of 21.0 g/1 in water at room
temperature, whereas the solubility of the DL/LD-I pair of
diastereomers is 0.4 g/l.
Besides the development of novel synthetic methods for
methionylmethionine, the present invention relates to the
use of DL-methionyl-DL-methionine as feedstuff as
DD/LL/DL/LD, DD/LL or DL/LD diastereomer mixture as growth
promoter for omnivorous, carnivorous and herbivorous fish
and crustaceans in aquacultures. It has thus been possible
to show inventively that DL-methionyl-DL-methionine (I) can
be cleaved under physiological conditions enzymatically by
fish and crustaceans to free D- and L-methionine (scheme 2)

WO 2010/043558 CA 02740663 2011-04-14 PCT/EP2009/063160
12
(see also examples 22 to 24). For this purpose, the
corresponding digestive enzymes have been isolated from
carp (omnivore), trout (carnivore) and whiteleg shrimp
(omnivore) and reacted with DL-methionyl-DL-methionine in
optimized in vitro experiments under physiologically
comparable conditions. The particular feature according to
the invention of the cleavage of DL-methionyl-DL-methionine
(I) is that all four possible diastereomers, both the
natural LL-I, and the three unnatural diastereomers DD-,
DL- and LD-I can be cleaved under physiological conditions.
This applies both to the use of the complete mixture of all
diastereomers (DD/LL/DL/LD-I), and in each case to the two
pairs of diastereomers DD/LL-I and DL/LD-I (see figure 1).
0
0 HO =
HN Digested NH2
enzymes L-Methionine
NH2
HP
cop
NH2
DID/ LL/DL/LD- (I)
D-Methionine
Trans-
amitlatien
NH2
L-Methionine
Scheme 2
However, the cleavage of the individual diastereomers of
methionylmethionine takes place at different rates. This is
illustrated by the diagrammatic representation of the
enzymatic cleavage of the individual diastereomers of

WO 2010/043558 CA 02740663 2011-04-14
PCT/EP2009/063160
13
methionylmethionine with digestive enzymes of fish and
crustaceans in figure 2. However, the delayed cleavage
means that the liberation of D- and L-methionine is
likewise delayed too (see figure 3). This has the great
advantage that there can be no fast-response absorption of
free D- or L-methionine in the digestive tract and thus no
concentration peak of free methionine in the blood plasma
either.
The advantage of using methionylmethionine as feed additive
and methionine source is thus that D- or L-methionine can
be liberated in the body over the whole digestion period
and thus proceeds synchronously with the release of other
amino acids derived from natural protein sources (slow-
release mechanism) (see figure 3). This special effect
results in the simultaneous availability of all the
important and essential amino acids in an ideal ratio in
the blood plasma being ensured, as is absolutely necessary
for an optimal growth of the body.
In the enzymatic cleavage of the DL-methionyl-DL-methionine
dipeptide (I), the unnatural D-methionine is also liberated
in addition to the natural L-methionine (see scheme 2). The
former can be enzymatically transaminated both by
carnivorous, omnivorous and herbivorous salt and fresh
water fish and crustaceans to give natural L-methionine. It
was possible to show this for the example of carp in
example 25. It was possible with the aid of an enzyme
cocktail of digestive and liver enzymes from carp to
transform D- into L-methionine under physiologically
corresponding conditions (see figure 4). An optimal supply
of natural L-methionine to the body is thus ensured on use
of DL-methionyl-DL-methionine (I).
The pelleting and extrusion experiments with various
mixtures of DL-methionyl-DL-methionine (I) and natural
protein and carbohydrate sources such as, for example,
fish, corn and soybean meal, and mixed with other essential

WO 2010/043558
PCT/EP2009/063160
CA 02740663 2011-04-14
14
amino acids, proteins, peptides, vitamins, minerals, fats
and oils, show that DL-methionyl-DL-methionine (I) is
absolutely stable during and after the production process
and no degradation or decomposition whatsoever occurs (see
example 26).
In order to investigate the leaching characteristics of the
diastereomers of methionylmethionine (I) from compound feed
pellets under water, the time-dependence of the dissolving
out of methionylmethionine was measured (see example 26).
For comparison, the leaching characteristics of
DL-methionine, MHA and calcium-MHA (MHA-Ca) were
investigated under identical conditions. It emerged from
this that both the complete mixture of all the
diastereomers (DD/LL/DL/LD-I) and the pairs of
diastereomers DD/LL-I and DL/LD-I show distinctly less
leaching than DL-methionine, MHA and calcium-MHA (MHA-Ca)
(see figure 5). Much less methionylmethionine is thus
dissolved out of the feed pellets over time than with all
other methionine derivatives. Particularly low leaching
rates are shown by the DL/LD-I pair of diastereomers, a
maximum of only 5% of which was dissolved out of the feed
pellets even after a residence time of 200 min (see
figure 5).
The object is further achieved by a process for preparing
DL-methionyl-DL-methionine (I) with the formula
0
NH2
S CO2H
(1)
by reacting a urea derivative of the general formula II

WO 2010/043558 CA 02740663 2011-04-14
PCT/EP2009/063160
01
R2
(II)
where the radicals Rl and R2 in the urea derivatives ha,
5 IIb, IIc, lid, Ile, IIf and hg are defined as follows:
where ha: = COOH, R2 = NHCONH2
lib: R1 = CONH2, R2 = NHCONH2
IIc: R1 = CONH2, R2 = NH2
lid: R1-R2 = -CONHCONH-
10 Ile: Rl = ON, R2 = OH
IIf: ON, R2 = NH2
hg: = =0, R2 = H
to give DL-methionyl-DL-methionine (I).
In one embodiment of the process of the invention it is
15 moreover preferred for methioninehydantoin (lid) to be used
as starting material or to be formed as intermediate
product. In this process, DL-methionyl-DL-methionine is
synthesized directly from methioninehydantoin and includes
methods G, H, and J shown in scheme 3.

WO 2010/043558 CA 02740663 2011-04-14 PCT/EP2009/063160
16
Method A
for ha and Ilb
0
Method BNH
tonic
Method C
for Ile and Ilf
0
Method D (III)
for hg
2
Method E Method F
R2
(II)
0
Method G HN
for ha, lib and lid
NH2
S
Method H CO2
for 11c, Ile and Ilf
DD/LL/DL/LD¨ (I)
Method J
for hg
Method K
DD/LL¨I DL/LD¨I
Scheme 3
It is preferred in this connection for a solution
comprising methioninehydantoin and water to be reacted with
methionine under basic conditions. It is further preferred
for the pH of the solution comprising the urea derivative
to be adjusted to from 8 to 14, preferably to from 10 to
13.
In a preferred manner, the reaction takes place at a
temperature of from 50 to 200 C, preferably at a
temperature of from 80 to 170 C and particularly preferably
at a temperature of from 130 to 160 C.
It is further preferred for the reaction to be carried out
under pressure, preferably under a pressure of from 3 to

WO 2010/043558 CA 02740663 2011-04-14
PCT/EP2009/063160
17
20 bar, particularly preferably under a pressure of from 6
to 15 bar.
In a further preferred process, a solution comprising
methioninehydantoin and water has previously been formed
from one or more of the compounds ha, lib, IIc, lid, lie,
IIf and IIg.
In a further preferred process, methioninehydantoin is
obtained by reacting the compound Ile or IIf with a
nitrogen-containing base, NH4HCO3, (NH4)2CO3,NH4 H/CO2
mixture or carbamate salts.
Reaction of the compound Ile is preferably carried out at a
temperature of from 0 C to 150 C, preferably 0 C to 100 C
and particularly preferably from 10 C to 70 C.
In a further preferred process, the methioninehydantoin is
obtained by reacting the compound IIf with CO2. It is
preferred in this connection for the reaction to take place
in the presence of a base, preferably selected from the
group comprising KHCO3, K2CO3, tertiary amines or salts
thereof, alkali metal and alkaline earth metal bases.
In a further preferred process, methioninehydantoin is
obtained by reacting the compound hg with a cyanide ion
source and a base selected from the group comprising
nitrogen-containing bases, ammonium salts in the presence
of CO2, NH4HCO3, (NH4)2CO3, NH4OH/CO2 mixture and carbamate
salts. The reaction in this case takes place at a
temperature of preferably -20 C to 150 C, preferably -10 C
to 100 C and particularly preferably from 0 C to 70 C.
alternative embodiment of the process of the invention
comprises the following steps:
a) reaction of the urea derivative of formulae ha, IIb,
IIc, lid, lie, IIf and hg to give a diketopiperazine of
the formula

WO 2010/043558
CA 02740663 2011-04-14
PCT/EP2009/063160
18
0
NH
HN
(III)
b) reaction of the diketopiperazine to give DL-methionyl-
DL-methionine. This process includes methods A, B, C and D
shown in scheme 3. In this process, diketopiperazine (III)
is formed as intermediate.
It is preferred in this connection for the reaction of the
urea derivatives to give the diketopiperazine to be carried
out at a temperature of from 50 C to 200 C, preferably from
100 C to 180 C and particularly preferably from 140 C to
170 C.
In a preferred process, the reaction of the urea derivative
to give the diketopiperazine takes place under pressure,
preferably under a pressure of from 3 to 20 bar,
particularly preferably under a pressure of from 6 to
15 bar.
The reaction of the urea derivative to give the
diketopiperazine preferably takes place in the presence of
a base. The base in this connection is preferably selected
from the group of nitrogen-containing bases, NH41-1CO3,
(N1-14)2CO3, KHCO3, K2CO3, NH401-1/CO2 mixture, carbamate salts,
alkali metal and alkaline earth metal bases.
In a further preferred process, the reaction of the urea
derivative to give the diketopiperazine takes place by
reaction with methionine. A ratio of urea derivative to
methionine of from 1:100 to 1:0.5 is preferred in this
connection.

WO 2010/043558 CA 02740663 2011-04-14
PCT/EP2009/063160
19
In a further preferred process, the reaction of the diketo-
piperazine to give DL-methionyl-DL-methionine takes place
by acidic hydrolysis. The acidic hydrolysis is in this case
carried out in the presence of an acid which is preferably
selected from the group of mineral acids, HC1, H2CO3,
CO2/H20, H2SO4 phosphoric acids, carboxylic acids and
hydroxy carboxylic acids.
In another embodiment of the process of the invention, the
reaction of the diketopiperazine to give DL-methionyl-DL-
methionine takes place by basic hydrolysis. In this case,
the basic hydrolysis is preferably carried out at a pH of
from 7 to 14, particularly preferably at a pH of from 9 to
12, very particularly preferably at a pH of from 10 to 11,
in order to obtain DL-methionyl-DL-methionine. It is
moreover possible for the basic conditions to be adjusted
by using a substance which is preferably selected from the
group of nitrogen-containing bases, NH4HCO3, (NH4)2CO3,
NH4OH/CO2 mixture, carbamate salts, KHCO3, K2CO3,
carbonates, alkali metal and alkaline earth metal bases.
The acidic or basic hydrolysis is preferably carried out at
temperatures of from 50 C to 200 C, preferably from 80 C to
180 C and particularly preferably from 90 C to 160 C.
In a further embodiment, the reaction of the
diketopiperazine to give DL-methionyl-DL-methionine is
carried out by introducing CO2 into a basic solution,
preferably into a basic ammonium hydroxide, potassium
hydroxide or sodium hydroxide solution.
In a preferred process, the diketopiperazine is isolated
before the hydrolysis. It is preferred in this connection
for the diketopiperazine to be isolated by crystallization
from the reaction solution, preferably at a temperature of
from -30 to 120 C, particularly preferably at a temperature
of from 10 to 70 C.

WO 2010/043558 CA 02740663 2011-04-14
PCT/EP2009/063160
To isolate the mixture of DD/LL/DL/LD-methionylmethionine
diastereomers from basic reaction solutions, they are
acidified and the methionylmethionine is obtained by
crystallization or precipitation. It is preferred in this
5 connection for the pH to be from 5 to 9, particularly
preferred for the pH to be from 5 to 7, and very
particularly preferred for the pH to be about 5.6. It is
possible in this connection to use acids preferably from
the group of mineral acids, HC1, H2CO3, CO2/H20, H2SO4,
10 phosphoric acids, carboxylic acids and hydroxy carboxylic
acids for the acidification.
To isolate the mixture of DD/LL/DL/LD-methionylmethionine
diastereomers from acidic reaction solutions, bases are
added to neutralize, and the methionylmethionine is
15 obtained by crystallization or precipitation. It is
preferred in this connection for the pH to be from 5 to 9,
particularly preferred for the pH to be from 5 to 7, and
very particularly preferred for the pH to be about 5.6. The
bases used in this case for the neutralization are
20 preferably from the group of NH4HCO3, (NH4)2CO3, nitrogen-
containing bases, NH4OH, carbamate salts, KHCO3, K2CO3,
carbonates, alkali metal and alkaline earth metal bases.
The invention further provides a process for fractionating
the mixture of DD/LL/DL/LD-methionylmethionine
diastereomers by fractional crystallization, thus obtaining
the two pairs of enantiomers DD/LL-methionylmethionine and
DL/LD-methionylmethionine.
In a preferred embodiment of the process of fractional
crystallization by acidification, the procedure is as
follows:
a) acidification of the DD/LL/DL/LD-methionylmethionine-
containing suspension until a clear solution is obtained,
and stepwise addition of a base to the acidic solution

WO 2010/043558 CA 02740663 2011-04-14
PCT/EP2009/063160
21
until a precipitate separates out results in DL/LD-
methionylmethionine as precipitate,
b) DD/LL-methionylmethionine is obtained from the mother
liquor obtained in step a).
It is particularly preferred in this connection for the
acidification in step a) to take place with an acid and for
a pH of from 0.1 to 1.0, preferably a pH of about 0.6, to
be set, and for the resulting clear solution subsequently
to be adjusted with a base to a pH of from 5 to 6,
preferably to a pH of about 5.6. It is possible to use as
acid in this connection mineral acids, preferably
phosphoric acid, sulfuric acid, hydrochloric acid or
carbonic acid, or carbon dioxide, and/or carboxylic acids,
especially the C1-C4 carboxylic acids formic acid, acetic
acid, propionic acid, butyric acid or isobutyric acid.
Carbonic acid or carbon dioxide is particularly preferably
used. It is possible in this case for the carbonic acid or
carbon dioxide to be introduced into the reaction mixture
under atmospheric pressure or under superatmospheric
pressure.
The basic conditions are adjusted in step a) preferably by
using a base selected from the group of NH4HCO3, (NH4)2CO3,
nitrogen-containing bases, NH4OH, carbamate salts, KHCO3,
K2CO3, carbonates, alkali metal bases and alkaline earth
metal bases.
In a further preferred embodiment of the process of
fractional crystallization by basification, the procedure
is as follows:
a) basification of the DD/LL/DL/LD-methionylmethionine-
containing suspension until a clear solution is obtained,
and stepwise addition of an acid to the basic solution
until a precipitate separates out results in DL/LD-
methionylmethionine as precipitate.

CA 02740663 2016-08-05
22
b) DD/LL-methionylmethionine is subsequently obtained from
the mother liquor obtained in step a).
It is particularly preferred in this connection for the
basification in step a) to take place with a base and for a
pH of from 7.5 to 14, preferably a pH of about 9 to 13, to
be adjusted, and for the resulting clear solution
subsequently to be adjusted with an acid to a pH of from 5
to 6, preferably to a pH of about 5.6. Bases preferably
used in this case are bases from the group NH4HCO3,
(NH4)2003, nitrogen-containing bases, NH4OH, carbamate
salts, KHCO3, K2CO3, carbonates, alkali metal and alkaline
earth metal bases.
The acidic conditions in step a) are preferably adjusted by
using an acid from the group of mineral acids, preferably
phosphoric acid, sulfuric acid, hydrochloric acid, or
carbonic acid or carbon dioxide, and/or from the group of
carboxylic acids, in particular the C1-C4 carboxylic acids
formic acid, acetic acid, propionic acid, butyric acid and
isobutyric acid. Carbonic acid or carbon dioxide is
particularly preferably used.
In a preferred embodiment of the process of fractional
crystallization, it takes place at a temperature of from
0 C to 100 C, preferably 5 C to 60 C and particularly
preferably from 10 C to 40 C.
The resulting DD/LL-methionylmethionine can moreover be
racemized and introduced into the separation process
described above, thus separating the two pairs of
enantiomers DD/LL-methionylmethionine and DL/LD-
methionylmethionine from one another.
According to one aspect of the present invention
there is provided a process for preparing DL-
methionyl-DL-methionine of the formula (I)

CA 02740663 2016-08-05
=
22a
0
NH2
CO2H
( I )
by reacting a urea derivative of the general formula
(II)
lo R2
( 11 )
where the radicals Rl and R2 in the urea derivatives ha,
lib, IIc, Ile and IIf are defined as follows:
where ha: Rl COOH, R2 = NHCONH2
lib: Rl = CONH2, R2 - NHCONH2
IIc: Rl CONH2, R2 - NH2
lie: R1 = CN, R2 OH
IIf: Rl = CN, R2 = NH2
to give DL-methionyl-DL-methionine.
According to a further aspect of the present
invention there is provided the process as
described herein, comprising the following steps:

CA 02740663 2016-08-05
22b
a) reaction of the urea derivative of formulae ha,
lib, IIc, Ile and IIf to give a diketopiperazine of
the formula (III)
0
NH
0
(III)
b) reaction of the diketopiperazine (III)to give DL-
methionyl-DL-methionine (I).
According to another aspect of the present invention
there is provided a process for isolating a mixture of
DD/LL/DL/LD- methionylmethionine diastereomers by
crystallization from a basic reaction solution which
has been obtained by a process as described herein.
According to yet another aspect of the present invention
there is provided a process for isolating a mixture of
DD/LL/DL/LD- methionylmethionine diastereomers by
crystallization from acidic reaction solution obtained
by a process as described herein.

CA 02740663 2016-08-05
22e
All the processes of the present invention which have been
mentioned are preferably carried out in an aqueous medium.

WO 2010/043558 CA 02740663 2011-04-14
PCT/EP2009/063160
23
The processes of the present invention can furthermore be
carried out in the batch process known to the skilled
worker or in continuous processes.
Figures
Figure 1 shows a diagrammatic representation of the
enzymatic cleavage of the methionylmethionine diastereomer
mixtures DD/LL-I, DL/LD-I and DD/LL/DL/LD-I.
Figure 2 shows a diagrammatic representation of the
enzymatic cleavage of the four methionylmethionine
diastereomers DD-I, LL-I, DL-I and LD-I with different
rates of cleavage.
Figure 3 shows a diagrammatic representation of the
enzymatic liberation of methionine (D- and L-Met together)
from the four methionylmethionine diastereomers DD-I, LL-I,
DL-I and LD-I.
Figure 4 shows the biotransformation of D-methionine to
L-methionine with an enzyme cocktail from common carp.
Figure 5 shows the leaching characteristics of
methionylmethionine diastereomer mixtures DD/LL-I, DL/LD-I
and LL/DD/LD/DL-I compared with methionine, MHA and MHA-Ca.
Figure 6 shows the in vitro digestion of four different
methionylmethionine diastereomers LL-I, LD-I, DL-I and DD-I
with digestive enzymes of the common carp.
Figure 7 shows the in vitro digestion of various
methionylmethionine diastereomer mixtures LL/DD-I, DL/LD-I
and LL/DD/LD/DL-I with digestive enzymes of the common
carp.
Figure 8 shows the in vitro digestion of four different
= methionylmethionine diastereomers LL-I, LD-I, DL-I and DD-I
with digestive enzymes of the rainbow trout.

WO 2010/043558 CA 02740663 2011-04-14
PCT/EP2009/063160
24
Figure 9 shows the in vitro digestion of the
methionylmethionine diastereomer mixtures LL/DD-I, DL/LD-I
and LL/DD/LD/DL-I with digestive enzymes of the rainbow
trout.
Figure 10 shows the in vitro digestion of four different
methionylmethionine diastereomers LL-I, LD-I, DL-I and DD-I
with digestive enzymes of the whiteleg shrimps.
Figure 11 shows the in vitro digestion of various
methionylmethionine diastereomer mixtures LL/DD-I, DL/LD-I
and LL/DD/LD/DL-I with digestive enzymes of the whiteleg
shrimps.
Examples
AO Overview of the individual steps and methods of the
process of the invention
The process of the invention for preparing DL-methionyl-DL-
methionine (I) and the separation into the DD/LL-I and
DL/LD-I pairs of diastereomers are described in detail
below.
The process of the invention for preparing DL-methionyl-DL-
methionine (I) starts from a compound of the general
formula II
1
R2
(II)
where ha: 121 = COOH, R2 = NHCONH2
IIb: 111 = CONH2, R2 = NHCONH2

WO 2010/043558 CA 02740663 2011-04-14
PCT/EP2009/063160
Ile: R1 = CONH2, R2 = NH2
lid: R1-R2 = -CONHCONH-
Ile: R1 = ON, R2 = OH
IIf: R1 = CN, R2 = NH2
5 hg: R1 - =0, R2 = H.
This compound is transformed by various synthetic methods
(AL, B, C, D, E, F, G, H and J) into DL-methionyl-DL-
methionine (I) (see scheme 3). In methods A, B, C, and D
therein, the corresponding diketopiperazine (III) is
10 produced as intermediate. In synthetic methods G, H and J,
methionine hydantoin is produced as intermediate and is
transformed directly into DL-methionyl-DL-methionine (I).
It is subsequently possible by fractional crystallization
by method K to separate the two pairs of diastereomers
15 DD/LL-I and DL/LD-I (see scheme 3).

WO 2010/043558 CA 02740663 2011-04-14
PCT/EP2009/063160
26
Method A
for Ha and lib
0
Method B SI,J.LNH
for Ilc
Method C HN
for Ile and Ilf 0
Method D (III)
for hg
Method E Method F
R2
(II)
Method G HNS
for ha, Ilb and lid
NH2
Method H S CO2H
for 11c, Ile and Ilf
DD/LL/DL/LD¨ (I)
Method J
for Hg
Method K
DD/LL-1 DL/LD¨/
Scheme 3

WO 2010/043558 CA 02740663 2011-04-14
PCT/EP2009/063160
27
B) Synthesis examples:
Example 1:
Synthesis of 3,6-bis[2-(methylthio)ethy1]-2,5-
piperazinedione (III) (methioninediketopiperazine, DKP)
from N-carbamoylmethionine (ha) by method A
17.5 g (90.0 mmol, purity: 99%) of N-carbamoylmethionine
(ha) were dissolved in 150 ml of water and stirred in a
200 ml Roth steel autoclave with magnetic stirring at 160 C
for 6 hours. The pressure rises during this. From time to
time, gas was repeatedly discharged until a pressure of
7 bar was reached. After completion of the reaction, the
autoclave was cooled in an ice bath. The resulting
suspension was then filtered, and the filtered solid was
washed several times with water and dried in a drying oven
at 50 C in vacuo. The isolated yield was 8.1 g (30.9 mmol)
(69%) of bis[2-(methylthio)ethy1]-2,5-piperazinedione
(III), yellowish white crystals, purity > 98% (HPLC),
melting point 234-236 C.
1H-NMR of 3,6-bis[2-(methylthio)ethy1]-2,5-piperazinedione
(III) (500 MHz, D6-DMS0): 8 = 1.85-2.05 (m, 4H, 2 x
SCH2CH2); 2.049 (s, 6H, 2 x SCH3); 2.46-2.60 (m, 4H, 2 x
SCH2); 3.92-3.99 (m, 2H, 2 x CH); 8.213 (s, 2H, 2 x NH)
13,C-NMR of 3,6-bis[2-(methylthio)ethy1]-2,5-piperazinedione
(III) (125.8 MHz, D6-DMS0): 8 = 14.35 (CH3); 14.38 (CH3);
28.50 (CH2S); 28.68 (CH2S); 31.92 (CH2CH2S); 32.33 (CH2CH2S);
52.92 (CH); 52.96 (CH); 167.69 (C=0); 167.71 (C=0)
Elemental analysis for C10H18N202S2 (M = 262.39 g/mol):
Calculated: C 45.77; H 6.91; N 10.68; S 24.44
Found: C 45.94; H 6.96; N 10.64; S 24.38

WO 2010/043558 CA 02740663 2011-04-14
PCT/EP2009/063160
= 28
Example 2:
Synthesis of 3,6-bis[2-(methylthio)ethy1]-2,5-
piperazinedione (III) (methioninediketopiperazine, DKP)
from 2-[(aminocarbonyl)amino]-4-(methylthio)butanoamide
(N-carbamoylmethioninamide) (lib) by method A
17.4 g (90.0 mmol, purity: 98.5%) of 2-[(aminocarbony1)-
amino]-4-(methylthio)butanoamide (lib) were dissolved in
150 ml of water and stirred in a 200 ml Roth steel
autoclave with magnetic stirring at 160 C for 7 hours. The
pressure rises during this. From time to time, gas was
repeatedly discharged until a pressure of 7 bar was
reached. After completion of the reaction, the autoclave
was cooled in an ice bath. The resulting suspension was
then filtered, and the filtered solid was washed several
times with water and dried in a drying oven at 50 C in
vacuo. The isolated yield was 9.2 g (35.1 mmol) (78%) of
bis[2-(methylthio)ethy1]-2,5-piperazinedione (III),
yellowish white crystals, purity > 98% (HPLC).
The melting point and the NMR data agreed with those of
example 1.
Example 3:
Synthesis of 3,6-bis[2-(methylthio)ethy1]-2,5-piperazine-
dione (III) (methioninediketopiperazine, DKP) from 5-[2-
(methylthio)ethy1]-2,4-imidazolidinedione (lid)
(methioninehydantoin) by method A and subsequent reuse of
the mother liquor (cascade reaction)
First batch:
A suspension of 13.4 g (0.09 mol) of methionine, 17.2 g
(0.09 mol, purity: 91%) of methioninehydantoin (lid) and
150 g of water were introduced into a 200 ml Roth steel

WO 2010/043558 CA 02740663 2011-04-14
PCT/EP2009/063160
29
autoclave with magnetic stirring and stirred at 160 C for
6 hours, during which the pressure rises to 15 bar. From
time to time, the autoclave was decompressed until the
pressure settled at a constant 10 bar. The autoclave was
then cooled in an ice bath, and the resulting suspension
was filtered and the solid was washed with 75 ml of water.
Finally, the solid was dried in a vacuum drying oven at
50 C overnight. Bis[2-(methylthio)ethy1]-2,5-piperazine-
dione (III) was isolated as yellowish white crystals.
Subsequent batches:
The washing water and the mother liquor from the preceding
batch were combined and concentrated to 90 ml in a rotary
evaporator at 50 C. 17.2 g (0.09 mol, purity: 91%) of
methioninehydantoin (lid) were taken up with the
concentrated mother liquor and made up to 150 g of solution
with water. The resulting solution was introduced into a
200 ml Roth steel autoclave with magnetic stirring and
stirred at 160 C for 6 hours, during which the pressure
rises to 15 bar. From time to time, the autoclave was
decompressed until the pressure remained constant at 10
bar. Further working up took place in analogy to the first
batch.
Example 4:
Synthesis of 3,6-bis[2-(methylthio)ethy1]-2,5-piperazine-
dione (III) (methioninediketopiperazine, DKP) from 2-amino-
4-(methylthio)butanoamide (methioninamide) (IIc) by method
16.6 g (0.09 mol) of 2-amino-4-(methylthio)butanoamide
hydrochloride (IIc) and 8.7 g (0.09 mol) of (1\11-14)2CO3 were
dissolved in 150 g of water and stirred in a 200 ml Roth
steel autoclave with magnetic stirring at 160 C for
6 hours. The autoclave was then cooled in an ice bath. The

WO 2010/043558 CA 02740663 2011-04-14
PCT/EP2009/063160
resulting suspension was then filtered, and the filtered
solid was washed several times with water and dried in a
drying oven at 50 C in vacuo. The isolated yield was 6.5 g
(24.8 mmol) (55%) of bis[2-(methylthio)ethy1]-2,5-
5 piperazinedione (III), yellowish white crystals, purity >
98% (HPLC).
The melting point and the NMR data agreed with those from
example 1.
10 Example 5:
Synthesis of 3,6-bis[2-(methylthio)ethy1]-2,5-piperazine-
dione (III) (methioninediketopiperazine, DKP) from
2-hydroxy-4-(methylthio)butanenitrile (3-(methyl-
mercapto)propionaldehyde cyanohydrin, MMP-CH) (Ile) by
15 method C
A solution of 30.5 g (0.232 mol) of 2-hydroxy-4-(methyl-
thio)butanenitrile (Ile) and 360 g of water was slowly
added dropwise at RT to a suspension of 22.4 g (0.283 mol =
1.22 eq.) of NH4HCO3 in 20 g of water and stirred for 2 h.
20 The NH4HCO3 dissolved during this. The resulting solution
was subsequently stirred at 50 C for 7 h and then at room
temperature overnight. The reaction mixture was then
transferred into a 500 ml steel autoclave, heated to 160 C,
and stirred at this temperature for 6 hours. The autoclave
25 was then cooled in an ice bath, the resulting suspension
was filtered, and the solid was washed with 50 ml of water.
Finally, the pale solid was dried in a vacuum drying oven
at 50 C overnight. The isolated yield was 17.8 g
(67.8 mmol) (58%) of bis[2-(methylthio)ethy1]-2,5-
30 piperazinedione (III), yellowish white crystals, purity >
98% (HPLC).
The melting point and the NMR data agreed with those from
example 1.

WO 2010/043558 CA 02740663 2011-04-14
PCT/EP2009/063160
31
Example 6:
Synthesis of 3,6-bis[2-(methylthio)ethy1]-2,5-piperazine-
dione (III) (methioninediketopiperazine, DKP) from 2-amino-
4-(methylthio)butanenitrile (methioninenitrile) (If) by
method C
A moderate stream of CO2 was passed into a solution of
26.2 g (0.201 mol) of 2-amino-4-(methylthio)butanenitrile
(If) in 330 g of water over a period of 3 hours, during
which the temperature rose to 45 C and the pH settled at 8.
Stirring was then continued at room temperature overnight.
The next morning, the reaction mixture was transferred into
a 500 ml steel autoclave, heated to 160 C and stirred at
this temperature for 6 hours. The autoclave was then cooled
in an ice bath, the resulting suspension was filtered, and
the solid was washed with 50 ml of water and dried in a
vacuum drying oven at 50 C overnight. The isolated yield
was 15.7 g (59.7 mmol) (59%) of bis[2-(methylthio)ethy1]-
2,5-piperazinedione (III), yellowish white crystals, purity
> 98% (HPLC).
The melting point and the NMR data agreed with those from
example 1.
Example 7:
Synthesis of 3,6-bis[2-(methylthio)ethy1]-2,5-piperazine-
dione (III) (methioninediketopiperazine, DKP) from
3-(methylthio)propanaldehyde (3-(methylmercapto)propion-
aldehyde, MMP) (hg) by method D
66.0 g (0.68 mol) of (NH4)2CO3 were introduced into 100 g
of water and cooled to 5 C in an ice bath. Then, over the
course of 25 minutes, 16.6 g (0.61 mol) of freshly
distilled hydrocyanic acid were added dropwise, during
which the temperature of the suspension was kept in the

WO 2010/043558 CA 02740663 2011-04-14
PCT/EP2009/063160
32
range from 5 to 10 C. Addition of 860 g of water was
followed by dropwise addition, at 10 C, of 60.3 g
(0.58 mol) of 3-(methylthio)propionaldehyde (hg) over a
period of 80 min. The pH remained constant in the range
from 8.5 to 9 during this. The reaction mixture was then
heated to 50 C and stirred at this temperature for 7 hours.
After completion of the reaction, the reaction mixture was
cooled to 5 C in an ice bath and stored in a refrigerator
overnight. The next morning, the mixture was transferred
into a 2 1 steel autoclave, heated to 160 C and stirred at
this temperature for 6 hours. The autoclave was then cooled
in an ice bath, the resulting suspension was filtered and
washed with 150 ml of water, and the solid was dried in a
vacuum drying oven at 50 C overnight. The isolated yield
was 48.6 g (185.2 mmol) (64%) of bis[2-(methylthio)ethy1]-
2,5-piperazinedione (III), yellowish white crystals, purity
> 98% (HPLC).
The melting point and the NMR data agreed with those from
example 1.
Example 8:
Synthesis of DD/LL/DL/LD-methionylmethionine (I) from 3,6-
bis[2-(methylthio)ethy1]-2,5-piperazinedione (III)
(methioninediketopiperazine, DKP) with concentrated
hydrochloric acid by method E
655.9 g (2.50 mol) of 3,6-bis[2-(methylthio)ethy1]-2,5-
piperazinedione (III) (DKP) were suspended in 1661 g of
water. While stirring, 271.0 g of conc. hydrochloric acid
were very slowly added dropwise and then cautiously heated,
with very vigorous stirring, to reflux. Severe foaming may
occur during this. The reaction mixture was heated to
reflux for 5.5 hours, thus dissolving all the solid. During
the subsequent cooling, unreacted DKP (III) precipitated

WO 2010/043558 CA 02740663 2011-04-14
PCT/EP2009/063160
33
and was filtered off. This DKP can be employed again for
further hydrolyses in later reactions. The filtrate was
then adjusted to pH 6 in a glass beaker in an ice bath with
32% strength aqueous ammonia. A DD/LL/DL/LD-
methionylmethionine (I) separates out as a thick mass of
crystals, and 50:50 mixture of the two pairs of
diastereomers (DL/LD-Met-Met) (DL/DL-I) and (DD/LL-Met-Met)
(DD/LL-I) during this. It was finally dried in a drying
oven at 60 C in vacuo. Yield: 601.0 g (2.14 mol) (85.7%) of
DD/LL/DL/LD-methionylmethionine (I), slightly yellowish
solid, purity 98% (HPLC).
1H-NMR of DD/LL/DL/LD-methionylmethionine (I) (500 MHz, D6-
DMSO+HC1): 8 = 1.86-2.16 (m, 4H, 2 x SCH2CH2); 2.050 (s,
3H, SCH3); 2.060 (s, 3H, SCH3); 2.44-2.64 (m, 4H, 2 x SCH2);
2.90-4,00 (m, 1H, CH); 4.32-4.42 (m, 1H, CH); 8.45 (bs, 3H,
NH3); 8.98-9.08 (m, 1H, 2 x NH)
13C-NMR of DD/LL/DL/LD-methionylmethionine (I) (125.8 MHz,
D6-DMSO+HC1): 8 = 14.33 (CH3); 14.38 (CH3); 27.74; 27.94;
29.51; 30.04; 30.13; 30.89; 30.95; 51.00; 51.29; 51.54 (CH,
CH2); 168.05 (CONH); 168.19 (CONH); 172.55 (COOH); 172.62
(COOH)
Elemental analysis for C10H20N203S2 (M = 280.41 g/mol):
Calculated: C 42.83; H 7.19; N 9.99; S 22.87
Found: C 42.61; H 7.19; N 10.06; S 22.72
Example 9:
Industrial synthesis of DD/LL/DL/LD-methionylmethionine (I)
from 3,6-bis[2-(methylthio)ethy1]-2,5-piperazinedione (III)
(methioninediketopiperazine, DKP) with concentrated
hydrochloric acid by method E
500 1 of water were introduced into a 500 1 enameled tank
with stirrer, 32 1 of concentrated hydrochloric acid and

WO 2010/043558 CA 02740663 2011-04-14
PCT/EP2009/063160
34
78.6 kg of 3,6-bis[2-(methylthio)ethy1]-2,5-piperazinedione
(III) (DKP) were added, and the apparatus was closed
tightly. It was then heated at 110 C while stirring for
2 hours, during which the pressure rose to 2.5 bar and the
DKP (III) virtually completely dissolved. After the
reaction was complete, the mixture was cooled to 20 C, and
the unreacted DKP was spun down in a centrifuge. The solid
was washed with 10 1 of water. The filtrate and washing
water were then collected in an 800 1 container and
subsequently introduced into a 500 1 tank with stirrer
again. Addition of 2 kg of activated carbon was followed by
stirring at 20 C for 30 min. The suspension was then
filtered through a filter press into a further 500 1 tank
with stirrer. About 28 1 of concentrated ammonia solution
were then added to precipitate at pH 6 the DD/LL/DL/LD-
methionylmethionine (I). During this there is initial
preferential precipitation of the less soluble racemic pair
of diastereomers DL/LD-methionylmethionine (DL/LD-I). This
was spun down and the mother liquor was concentrated
together with washing water to one quarter of the original
volume in vapor pump vacuum at an internal temperature not
exceeding 40 C. During this, the more soluble racemic pair
of diastereomers DD/LL-methionylmethionine (DD/LL-I)
crystallized together with small amounts of the slightly
soluble DL/LD-I. Completion of the distillation was
followed by cooling to 20 C and centrifugation. The
separated mother liquor and washing water were discarded.
Both fractions were dried in vacuo at 70 C. In total, it
was possible to obtain 64.2 kg (78%) of DD/LL/DL/LD-
methionylmethionine (I) as mixture of diastereomers. Purity
> 98% (HPLC).
The melting point and the NMR data agreed with those from
example 8.

WO 2010/043558 CA 02740663 2011-04-14
PCT/EP2009/063160
Example 10:
Synthesis of DD/LL/DL/LD-methionylmethionine (I) from 3,6-
bis[2-(methylthio)ethy1]-2,5-piperazinedione (III)
(methioninediketopiperazine, DKP) under alkaline
5 conditions, e.g. with ammonia by method F
65.6 g (0.25 mol) of 3,6-bis[2-(methylthio)ethy1]-2,5-
piperazinedione (III) (DKP), 70 ml of 25% strength ammonia
solution and 500 ml of water are heated at 150 C in an
autoclave for 2 hours. After cooling, the unreacted DKP
10 (III) (16.0 g = 24.4%) is filtered off with suction. This
can be employed again in a subsequent batch. The filtrate
was concentrated in a rotary evaporator at a water
temperature of 80-90 C until the first crystals separated
out. After cooling and leaving to stand overnight it was
15 possible to isolate after filtration and drying in total
49.3 g (70.3%) of DD/LL/DL/LD-methionylmethionine (I) as
50:50 mixture of the two pairs of diastereomers DL/DL-I and
DD/LL-I as a white solid. Purity 98% (HPLC).
The melting point and the NMR data agreed with those from
20 example 8.
Example 11:
Purification of DD/LL/DL/LD-methionylmethionine (I)
500 g of DD/LL/DL/LD-methionylmethionine (I) were suspended
25 in 7800 g of deionized water (pH 5.3). At 26 C, the pH was
adjusted to 1.0 with 346.6 g of 50% by weight sulfuric
acid. The methionylmethionine dissolved completely. For
clarification, 18 g of activated carbon were added to the
yellowish turbid solution and stirred for 60 minutes. The
30 activated carbon was filtered off, and the clear colorless
solution was adjusted to pH 5.6 with 228 g of 32% by weight
ammonia solution. The solution was left to stand overnight.

WO 2010/043558 CA 02740663 2011-04-14
PCT/EP2009/063160
36
The precipitated white solid was filtered off with suction
and dried in a drying oven at 50 C in vacuo. Yield: 460.5 g
(92%) of DD/LL/DL/LD-methionylmethionine (I), brilliant
white solid, purity > 99% (HPLC).
The NMR data agreed with those from example 8.
Example 12:
Synthesis of DD/LL/DL/LD-methionylmethionine (I) from
N-carbamoylmethionine (ha) and DL-methionine with KOH by
method G
13.4 g (0.09 mol) of DL-methionine, 17.5 g (0.09 mol,
purity: 99%) of N-carbamoylmethionine (ha) and 11.9 g
(0.18 mol) of 85% pure KOH were dissolved in 150 ml of
water and stirred at 150 C in a 200 ml Roth steel autoclave
with magnetic stirring for 5 hours, during which the
pressure rose to 6 bar. After reaction was complete, the
autoclave was cooled, and the precipitated 3,6-bis[2-
(methylthio)ethy1]-2,5-piperazinedione (III)
(methioninediketopiperazine, DKP) was filtered off and
washed with a little water. The washing water and the
mother liquor were combined and concentrated to a volume of
130 ml in a rotary evaporator at 40 C. A moderate stream of
CO2 was then passed into the resulting solution until a pH
of 6.4 was reached and a white solid precipitated. This was
filtered off, washed with a little cold water and dried in
a vacuum drying oven at 50 C overnight. The isolated yield
was 11.4 g (40.6 mmol) (45%) of DD/LL/DL/LD-
methionylmethionine (I), white solid, purity > 98% (HPLC).
The NMR data agreed with those from example 8.
Example 13:

WO 2010/043558 CA 02740663 2011-04-14
PCT/EP2009/063160
37
Synthesis of DD/LL/DL/LD-methionylmethionine (I) from 5-[2-
(methylthio)ethy1]-2,4-imidazolidinedione (lid)
(methioninehydantoin) and DL-methionine with KOH by method
13.4 g (0.09 mol) of DL-methionine, 17.2 g (0.09 mol,
purity: 91%) of methioninehydantoin (lid) and 8.9 g
(0.135 mol) of 85% pure KOH were dissolved in 150 ml of
water and stirred at 150 C in a 200 ml Roth steel autoclave
with magnetic stirring for 5 hours, during which the
pressure rises to 8 bar. After the reaction was complete,
the autoclave was cooled, the resulting suspension was
filtered and the precipitated 3,6-bis[2-(methylthio)ethyl]-
2,5-piperazinedione (III) (methioninediketopiperazine, DKP)
was washed several times with a little water. Mother liquor
and washing water were combined, and the resulting solution
was concentrated to a volume of 125 ml in a rotary
evaporator at 40 C. The concentrate was cautiously
neutralized with concentrated hydrochloric acid. A white
solid precipitated on stirring at room temperature and at a
pH of 5.8 overnight: This solid was filtered off, washed
with a little cold water and dried in a vacuum drying oven
at 50 C overnight. The isolated yield was 17.5 g
(62.4 mmol) (69%) of DD/LL/DL/LD-methionylmethionine (I),
white solid, purity > 98% (HPLC).
The NMR data agreed with those from example 8.

WO 2010/043558 CA 02740663 2011-04-14
PCT/EP2009/063160
38
Example 14:
Synthesis of DD/LL/DL/LD-methionylmethionine (I) from 5-[2-
(methylthio)ethy1]-2,4-imidazolidinedione (lid)
(methioninehydantoin) and DL-methionine with K2CO3 by
method G
13.4 g (0.09 mol) of DL-methionine, 17.2 g (0.09 mol,
purity: 91%) of methioninehydantoin (lid) and 12.4 g (0.09
mol) of K2CO3 were dissolved in 150 ml of water and stirred
at 150 C in a 200 ml Roth steel autoclave with magnetic
stirring for 5 hours, during which the pressure rises to
12 bar. After the reaction was complete, the autoclave was
cooled, and the precipitated 3,6-bis[2-(methylthio)ethy1]-
2,5-piperazinedione (III) (methioninediketopiperazine, DKP)
was filtered off and washed with a little water. The
washing water and the mother liquor were combined and
concentrated to a volume of 135 ml in a rotary evaporator
at 40 C. A moderate stream of CO2 was then passed into the
resulting solution until a pH of 6.8 was reached and a
white solid precipitated. This was filtered off, washed
with a little cold water and dried in a vacuum drying oven
at 50 C overnight. Yield: 14.3 g (60.0 mmol) (57%) of
DD/LL/DL/LD-methionylmethionine (I), white solid, purity >
99% (HPLC).
The NMR data agreed with those from example 8.
Example 15:
Synthesis of DD/LL/DL/LD-methionylmethionine (I) from 5-(2-
(methylthio)ethy1]-2,4-imidazolidinedione (lid)
(methioninehydantoin) and DL-methionine with KHCO3 by
method G
13.4 g (0.09 mol) of DL-methionine, 17.2 g (0.09 mol,
purity: 91%) of methioninehydantoin (lid) and 9.1 g (0.09

WO 2010/043558 CA 02740663 2011-04-14
PCT/EP2009/063160
39
mol) of KHCO3 were dissolved in 150 ml of water and stirred
at 150 C in a 200 ml Roth steel autoclave with magnetic
stirring for 5 hours, during which the pressure rises to
12 bar. After the reaction was complete, the autoclave was
cooled, and the precipitated 3,6-bis[2-(methylthio)ethy1]-
2,5-piperazinedione (III) (methioninediketopiperazine, DKP)
was filtered off and washed with a little water. The
washing water and the mother liquor were combined and
concentrated to a volume of 120 ml in a rotary evaporator
at 40 C. A moderate stream of CO2 was then passed into the
resulting solution until a pH of 6.3 was reached and a
white solid precipitated. This was filtered off, washed
with a little cold water and dried in a vacuum drying oven
at 50 C overnight. Yield: 16.0 g (57.1 mmol) (63%) of
DD/LL/DL/LD-methionylmethionine (I), white solid, purity >
99% (HPLC).
The NMR data agreed with those from example 8.
Example 16:
Synthesis of DD/LL/DL/LD-methionylmethionine (I) from
2-amino-4-(methylthio)butanoamide (IIc) (methioninamide)
and DL-methionine with (NH4)2CO3 by method H
8.3 g (0.045 mol) of 2-amino-4-(methylthio)butanoamide
(IIc) hydrochloride, 6.7 g (0.045 mol) of methionine, 4.3 g
(0.045 mol) of (NH4)2CO3 and 3.0 g (0.045 mol) of 85% pure
KOH were dissolved in 75 g of water and stirred at 160 C in
a 200 ml Roth steel autoclave with magnetic stirring for
6 hours. The autoclave was then cooled in an ice bath, the
resulting suspension was filtered off, and the precipitated
3,6-bis[2-(methylthio)ethy1]-2,5-piperazinedione (III)
(methioninediketopiperazine, DKP) was washed with a little
water. The washing water and the mother liquor were
combined and concentrated to a volume of 70 ml in a rotary

WO 2010/043558 CA 02740663 2011-04-14
PCT/EP2009/063160
evaporator at 40 C. A moderate stream of CO2 was then
passed into the resulting solution until a pH of 6.3 was
reached and a white solid precipitated. This was filtered
off, washed with a little cold water and dried in a vacuum
5 drying oven at 50 C overnight. Yield: 7.8 g (27.8 mmol)
(62%) of DD/LL/DL/LD-methionylmethionine (I), white solid,
purity > 98% (HPLC).
The NMR data agreed with those from example 8.
10 Example 17:
Synthesis of DD/LL/DL/LD-methionylmethionine (I) from
2-hydroxy-4-(methylthio)butanenitrile (IIe) (3-(methyl-
mercapto)propionaldehyde cyanohydrin, MMP-CH) and DL-
methionine with NH4HCO3 by method H
15 15.2 g (0.116 mol) of 2-hydroxy-4-(methylthio)butanenitrile
(Ile) were slowly added dropwise at RT to a suspension of
11.1 g (0.141 mol = 1.22 eq.) of NH4HCO3 in 10 g of water
and stirred for 2 h. The NH4HCO3 dissolved during this.
Then 180 g of water were added and the resulting solution
20 was stirred at 50 C for 7 h and at room temperature
overnight. The next morning, 17.3 g (0.116 mol) of
methionine, 7.7 g (0.116 mol) of 85% pure KOH and a further
180 g of water were added, and the reaction mixture was
transferred into a 1 1 steel autoclave, heated to 160 C and
25 stirred at this temperature for 6 hours. The autoclave was
then cooled in an ice bath, the resulting suspension was
filtered, and the precipitated 3,6-bis[2-(methylthio)-
ethy1]-2,5-piperazinedione (III) (methioninediketo-
piperazine, DKP) was washed with 100 ml of water. Mother
30 liquor and washing water were combined, and the resulting
solution was concentrated to a volume of 160 ml in a rotary
evaporator at 40 C. The concentrate was cautiously
neutralized with 50% strength sulfuric acid. A white solid

WO 2010/043558 CA 02740663 2011-04-14
PCT/EP2009/063160
41
precipitated on stirring at room temperature and at a pH of
5.4 overnight. This solid was filtered off, washed with a
little cold water and dried in a vacuum drying oven at 50 C
overnight. Yield: 15.2 g (54.2 mmol) (47%) of DD/LL/DL/LD-
methionylmethionine (I), white solid, purity > 99% (HPLC).
The NMR data agreed with those from example 8.
Example 18:
Synthesis of DD/LL/DL/LD-methionylmethionine (I) from
2-amino-4-(methylthio)butanenitrile (If) (methionine-
nitrile) with CO2 and DL-methionine by method H
A moderate stream of CO2 was passed into a solution of
26.2 g (0.201 mol) of 2-amino-4-(methylthio)butanenitrile
(If) in 330 g of water over a period of 3 hours, during
which the temperature rose to 45 C and the pH settled at 8.
Stirring was then continued at room temperature overnight.
The next morning, the reaction mixture was mixed with
30.0 g (0.201 mol) of methionine and 13.3 g (0.201 mol) of
85% pure KOH and transferred into a 1 1 steel autoclave,
heated to 160 C and stirred at this temperature for
6 hours. The autoclave was then cooled in an ice bath, the
resulting suspension was filtered, and the precipitated
3,6-bis[2-(methylthio)ethy1]-2,5-piperazinedione (III)
(methioninediketopiperazine, DKP) was washed with a little
water. The washing water and the mother liquor were
combined and concentrated to a volume of 280 ml in a rotary
evaporator at 40 C. A moderate stream of CO2 was then
passed into the resulting solution until a pH of 6.0 was
reached and a white solid precipitated. This was filtered
off, washed with a little cold water and dried in a vacuum
drying oven at 50 C overnight. Yield: 32.7 g (116.6 mmol)
(58%) of DD/LL/DL/LD-methionylmethionine (I), white solid,
purity > 98% (HPLC).

WO 2010/043558 CA 02740663 2011-04-14
PCT/EP2009/063160
42
The NMR data agreed with those from example 8.
Example 19:
Synthesis of DD/LL/DL/LD-methionylmethionine (I) from
3-(methylthio)propanaldehyde (hg) (414P) with hydrocyanic
acid, ammonium carbonate and DL-methionine by method J
66.0 g (0.68 mol) of (NH4)2CO3 were introduced into 100 g of
water and cooled to 5 C in an ice bath. Then 16.55 g
(0.612 mol) of freshly distilled hydrocyanic acid were
added dropwise over the course of 25 min, during which the
temperature of the suspension was kept at 5 to 10 C. After
500 g of water had been added, 60.3 g (0.58 mol) of
3-(methylthio)propionaldehyde (hg) were added dropwise at
1000 over a period of 80 min. The pH remained constant in
the range from 8.5 to 9 during this. The reaction mixture
was then heated to 50 C and stirred at this temperature for
7 hours. 'After the reaction was complete, the reaction
mixture was cooled to 5 C in an ice bath and stored in a
refrigerator overnight. The next morning, 86.5 g (0.58 mol)
2-amino-4-(methylthio)butanoic acid (methionine), 38.3 g
(0.58 mol) of 85% pure KOH (0.58 mol), and a further 530 g
of water were added. The mixture was transferred into a 2 1
steel autoclave, heated to 160 C and stirred at this
temperature for 6 hours. The autoclave was then cooled in
an ice bath, the resulting suspension was filtered, and the
precipitated 3,6-bis[2-(methylthio)ethy1]-2,5-piperazine-
dione (III) (methioninediketopiperazine, DKP) was washed
with a little water. The washing water and the mother
liquor were combined and concentrated to a volume of 800 ml
in a rotary evaporator at 40 C. A moderate stream of CO2
was then passed into the resulting solution until a pH of
6.0 was reached and a white solid precipitated. This was
filtered off, washed with a little cold water and dried in
a vacuum drying oven at 50 C overnight. Yield: 85.1 g

WO 2010/043558 CA 02740663 2011-04-14
PCT/EP2009/063160
43
(0.30 mol) (52%) of DD/LL/DL/LD-methionylmethionine (I),
white solid, purity > 98% (HPLC).
The NMR data agreed with those from example 8.
Example 20:
Separation of the two pairs of diastereomers DD/LL-
methionylmethionine (DD/LL-I) and DL/LD-methionylmethionine
(DL/LD-I) by fractional crystallization from DD/LL/DL/LD-
methionylmethionine (I) by method K
a) DL/LD-Methionylmethionine (DL/LD-I):
290.4 g of DD/LL/DL/LD-methionylmethionine (I) (50:50
mixture of DD/LL-I and DL/LD-I) were suspended in 2614 g of
deionized water and adjusted to pH 0.6 with 381.7 g of 50%
by weight sulfuric acid. The clear colorless solution was
adjusted to pH 5.6 with 265.9 g of 32% by weight ammonia
solution, and the resulting white precipitate was filtered
off with suction (580.9 g moist). The solid was finally
dried in a drying oven in vacuo at 50 C. The yield was
126.2 g (86.9%) of DL/LD-methionylmethionine (DL/LD-I),
white solid, purity > 98% (HPLC), melting range 232-233 C
(decomp.).
1H-NMR of DL/LD-methionylmethionine (DL/LD-I) (500 MHz,
D6-DMSO+HC1): 1.88-2.12 (m, 4H, 2 x SCH2CH2); 2.031 (s, 3H,
CH3); 2.041 (s, 3H, CH3); 2.48-2.56 (m, 4H, 2 x SCH2); 3.87-
3.95 (m, 1H, CH); 4.30-4.38 (m, 1H, CH); 8.429 (d, 3H, 3J =
4.4Hz, NH3+); 9.034 (d, 1H, 3J = 8.0Hz, NH)
13C-NMR of DL/LD-methionylmethionine (DL/LD-I) (125.8 MHz,
= D6-DMSO+HC1): 14.57 (CH3); 14.62 (CH3); 28.19; 29.75; 30.28;
31.19; 51.25 (CH); 51.79 (CH); 168.29 (CONH); 172.80 (COOH)
Solubility (water, 20 C): 0.4 g/1

WO 2010/043558 CA 02740663 2011-04-14
PCT/EP2009/063160
44
b) DD/LL-Methionylmethionine (DD/LL-I):
The colorless mother liquor from a) was concentrated in a
rotary evaporator at 35 C under water pump vacuum. A white
suspension was obtained. The white solid composed of
ammonium sulfate, residues of DL/LD-I and target compound
was then filtered off with suction and dried in vacuo at
50 C. The three solids were separated by suspending the
mixture in deionized water and stirring. The undissolved
DL/LD-I was filtered off with suction, and the mother
liquor was concentrated to about one fifth in a rotary
evaporator at 50 C under water pump vacuum. After prolonged
standing, DD/LL-methionylmethionine (DD/LL-I) crystallized
as a white solid. It was finally filtered off with suction
and dried in a vacuum drying oven at 50 C. The yield was
78.2 g (53.9%) based on DD/LL-methionylmethionine (DD/LL-
I), white solid, > 96% (HPLC), melting range 226-227 C
(decomposition).
1H-NMR of DD/LL-methionylmethionine (DD/LL-I) (500 MHz,
D6-DMSO+HC1): 1.84-2.12 (m, 4H, 2 x SCH2CH2); 2.044 (s, 3H,
CH3); 2.046 (s, 3H, CH3); 2.48-2.62 (m, 4H, 2 x SCH2); 3.89-
3.97 (m, 1H, CH); 4.33-4.40 (m, 1H, CH); 8.422 (d, 3H, 3J =
4.0Hz, NH3); 9.065 (d, 1H, 3J - 7.5Hz, NH)
13(C-NMR of DD/LL-methionylmethionine (DD/LL-I) (125.8 MHz,
D5-DMSO+HC1): 14.56 (CH3); 14.57 (CH3); 27.97; 29.73; 30.35;
31.11; 51.22 (CH); 51.50 (CH); 168.41 (CONH); 172.83 (COON)
Solubility (water, 20 C): 21.0 g/1
Example 21:
Racemization of the two pairs of diastereomers DD/LL-
methionylmethionine (DD/LL-I) and DL/LD-methionylmethionine
(DL/LD-I) under basic conditions

WO 2010/043558 CA 02740663 2011-04-14
PCT/EP2009/063160
a) Racemization of DL/LD-methionylmethionine (DL/LD-I)
12.6 g (45.0 mmol) of the pair of diastereomers DL/LD-
methionylmethionine (DL/LD-I) were dissolved together with
3.1 g (22.5 mmol) of K2CO3 in 75 ml of water in a 200 ml
5 Roth laboratory reactor and heated to 160 C while stirring.
The pressure rose to 7 bar during this. After 6 hours at
this temperature, the autoclave was cooled in an ice bath.
The resulting suspension was then filtered, and the solid
was filtered off, washed several times with water and dried
10 in a drying oven in vacuo at 50 C. The isolated yield was
6.5 g (24.8 mmol) (55%) of bis[2-(methylthio)ethy1]-2,5-
piperazinedione (III), yellowish white crystals, purity >
98%, melting point 234-236 C; diastereomer ratio: 52:48
(DD/LL-III : meso-III). The washing water and the mother
15 liquor were combined and concentrated to a volume of 25 ml
in a rotary evaporator at 40 C. A moderate stream of CO2
was then passed into the resulting solution until the pH
reached 6.0 and a white solid precipitated. This was
filtered off, washed with a little cold water and dried in
20 a vacuum drying oven at 50 C overnight. The isolated yield
was 5.7 g (20.3 mmol) (45%) of DD/LL/DL/LD-
methionylmethionine (I), white solid, purity > 98% (HPLC).
The NMR data agreed with those from example 8.
25 a) Racemization of DL/LD-methionylmethionine (DD/LL-I)
12.6 g (45.0 mmol) of DD/LL-methionylmethionine (DD/LL-I)
were dissolved together with 4.5 g (45.0 mmol) of KHCO3 in
75 ml of water in a 200 ml Roth laboratory reactor and
heated to 160 C while stirring. The pressure rose to 7 bar
30 and, after 6 hours at this temperature, the autoclave was
cooled in an ice bath. The resulting suspension was then
filtered, and the filtered solid was washed several times
with water and dried in a drying oven in vacuo at 50 C. The

WO 2010/043558 CA 02740663 2011-04-14
PCT/EP2009/063160
46
isolated yield was 6.0 g (22.9 mmol) (51%) of bis[2-
(methylthio)ethy1]-2,5-piperazinedione (III), yellowish
white crystals, purity > 98% (HPLC), melting point 233-
236 C; diastereomer ratio: 54:46 (DD/LL-III : meso-III).
The washing water and the mother liquor were combined and
concentrated to a volume of 25 ml in a rotary evaporator at
40 C. A moderate stream of CO2 was then passed into the
resulting solution until the pH reached 6.0 and a white
solid precipitated. This was filtered off, washed with a
little cold water and dried in a vacuum drying oven at 50 C
overnight. The isolated yield was 5.5 g (19.6 mmol) (44%)
of DD/LL/DL/LD-methionylmethionine (I), white solid, purity
> 98% (HPLC).
The NMR data agreed with those from example 8.
Example 22:
In vitro digestion experiments on DL-methionyl-DL-
methionine (I) with digestive enzymes from omnivorous carp
a) Isolation of the digestive enzymes from common carp
(Cyprinus carpio morpha noblis)
The method for isolating the digestive enzymes was based on
that of EID and MATTY (Aquaculture 1989, 79, 111-119). For
this purpose, the intestine of five one-year old common
carp (Cyprinus carpio morpha noblis) was exposed, rinsed
with water and cut open longitudinally, and in each case
the intestinal mucosa was scraped off. This was comminuted
together with crushed ice using a mixer. The resulting
suspension was treated with an ultrasonic probe in order to
disrupt cells which were still intact. The cell
constituents and fat were separated by centrifuging the
suspension at 4 C for 30 minutes, and the homogenate was
decanted off and sterilized with a trace of thimerosal.
260.7 ml of enzyme solution from the intestinal mucosa were

WO 2010/043558 CA 02740663 2011-04-14
PCT/EP2009/063160
47
obtained from 5 common carp, and the solution was stored in
the dark at 4 C.
b) Procedure for the in vitro digestion investigations
DL-Methionyl-DL-methionine (I) and the corresponding pairs
of diastereomers DD/LL-I and DL/LD-I were taken up in
TRIS/HC1 buffer solution and mixed with the enzyme
solution. A blank was made up in each case without enzyme
solution for comparison and to estimate the purely chemical
cleavage rate. A sample was taken from time to time, and
the composition thereof was detected and quantified with
the aid of a calibrated HPLC. The conversion was determined
as the quotient of the area for methionine and the area for
methionylmethionine (I) (see figure 6 and 7).
Table 1
Sample Blank
Precharge Substrate 0.143 mmol 0.143 mmol
Met-Met (I) (40.1 mg) (40.1 mg)
TRIS/HC1 buffer 5.7 ml 8.3 ml
solution,
pH 9.5
Reaction start Enzyme solution 2.6 ml
(A 5% carp
solution)
Reaction 37 C 37 C
Reaction stop 0.2 ml of reaction solution was taken up in
9.8 ml of 10% strength H3PO4 solution.

WO 2010/043558 CA 02740663 2011-04-14
PCT/EP2009/063160
48
Example 23:
In vitro digestion experiment on DL-methionyl-DL-methionine
(I) with digestive enzymes from carnivorous trout
a) Isolation of the digestive enzymes from rainbow trout
(Oncorhynchus mykiss)
The method for isolating the digestive enzymes was based on
that of EID and NATTY (Aquaculture 1989, 79, 111-119). For
this purpose, the intestine of six one-year old rainbow
trout (Oncorhynchus mykiss) was exposed and processed as
described in example 22.
b) Procedure for the in vitro digestion investigations
The in vitro investigations were carried out in analogy to
example 22 (see figure 8 and 9).
Table 2
Sample Blank
Precharge Substrate 0.143 mmol 0.143 mmol
Met-Met(I) (40.1 mg) (40.1 mg)
TRIS/HC1 buffer 5.7 ml 9.8 ml
solution,
pH 9.5
Reaction start Enzyme solution 4.2 ml
(A10% trout
solution)
Reaction 37 C 37 C
Reaction stop 0.2 ml of reaction solution was taken up in
9.8 ml of 10% strength H3PO4 solution.

WO 2010/043558 CA 02740663 2011-04-14
PCT/EP2009/063160
49
Example 24:
In vitro digestion experiments on DL-methionyl-DL-
methionine (I) with digestive enzymes from omnivorous
shrimps
a) Isolation of the digestive enzymes from whiteleg shrimps
(Litopenaeus Vannamei)
The method for isolating the digestive enzymes was based on
that of Ezquerra and Garcia-Carreno (J. Food Biochem. 1999,
23, 59-74). For this purpose, the hepatopancreas was
removed from five kilograms of whiteleg shrimps
(Litopenaeus Vannamei) and comminuted together with crushed
ice using a mixer. The further processing was carried out
in analogy to example 22.
b) Procedure for the in vitro digestion investigations
The in vitro investigations were carried out in analogy to
example 22 (see figure 10 and 11).
Table 3
Sample Blank
Precharge Substrate 0.143 mmol 0.143 mmol
Met-Met (I) (40.1 mg) (40.1 mg)
TRIS/HC1 buffer 5.7 ml 7.9 ml
solution,
pH 9.5
Reaction start Enzyme solution 2.2 ml
(.4- 2 shrimps)
Reaction 37 C 37 C

WO 2010/043558
PCT/EP2009/063160
CA 02740663 2011-04-14
Reaction stop 0.2 ml of reaction solution was taken up in
9.8 ml of 10% strength H3PO4 solution.
Example 25:
Biotransformation of D- to L-methionine with enzymes from
intestine, liver and pancreas of common carp
5 a) Isolation of the digestive enzymes from common carp
(Cyprinus carpio morpha noblis)
The method for isolating the digestive enzymes was based on
that of EID and MATTY (Aquaculture 1989, 79, 111-119). For
this purpose, the intestine of five one-year old common
10 carp (Cyprinus carpio morpha noblis) was exposed and
processed as described in example 22. To isolate liver
enzymes, the livers were isolated, homogenized and treated
in analogy to the processing of the intestinal enzymes in
example 22. The procedure for enzyme isolation from the
15 pancreas was also analogous thereto.
b) Procedure for the in vitro biotransformation of D- to
L-methionine
D-Methionine was taken up in buffer solution, and the
enzyme solution was added. A blank without enzyme solution
20 was made up in each case as comparison and for estimating
the purely chemical transformation rate. After 24 hours, a
sample was taken and the composition was detected and
quantified with the aid of calibrated HPLC. The conversion
was determined as the quotient of the area for L-methionine
25 and the area for D-methionine (see figure 4).

WO 2010/043558 CA 02740663 2011-04-14
PCT/EP2009/063160
51
Table 4
Sample Blank
Precharge Substrate 0.143 mmol 0.143 mmol
D-Methionine (21.3 mg) (21.3 mg)
Buffer solution 11.7 ml 23.4 ml
Reaction start Enzyme cocktail 11.7 ml
(A5% carp
solution)
Reaction 37 C 37 C
Reaction stop 0.2 ml of reaction solution was taken up in
9.8 ml of 10% strength H3PO4 solution.
Buffer solutions:
Citrate buffer: pH 5, pH 6 and pH 7
Phosphate buffer: pH 8
TRIS/HC1 buffer: pH 9
Enzyme cocktail composed of intestinal, hepatic and
pancreatic enzymes (A5% carp solution):
2.6 ml of enzyme solution from intestinal mucosa
3.5 ml of enzyme solution from liver
5.6 ml of enzyme solution from pancreas
Example 26:
Leaching characteristics of the mixtures of
methionylmethionine diastereomers LL/DD/LD/DL-I, DD/LL-I
and DL/LD-I from feed pellets compared with DL-methionine,
MHA and calcium MHA

WO 2010/043558 CA 02740663 2011-04-14
PCT/EP2009/063160
52
Feed mixture:
The feed matrix used was a methionine-deficient feed
mixture of conventional ingredients such as, for example,
soybean meal, soybean oil, cornstarch, wheat meal, fish
meal, cellulose, crystalline essential amino acids and
minerals and vitamins as premixes. This mixture was then
supplemented batchwise in 20 kg batches in each case with
the methionine derivatives stated in table 5, with a 0.25%
supplementation rate (based on sulfur equivalents), and was
homogenized and then pelleted with steam treatment. As
comparison with methionylmethionine (I), a pelleting
experiment was carried out in each case with DL-methionine,
MHA (methionine hydroxy analog) and calcium MHA. In
addition, a control experiment was carried out by pelleting
without addition of a methionine derivative (see table 5).
Table 5
Molecular
Purity Initial
No. Methionine derivative mass
(wt%) weight
(monomer)
1 No additive 0.00 g
2 DL-Methionine 99.0% 149.21 50.61 g
3 MHA 88.0% 150.19 57.14 g
4 Calcium MHA (MHA-Ca) 93.3% 169.22 60.77 g
DD/LL/DL/LD methionyl-
5 99.7% 140.20 47.13 g
methionine (I)
All the diastereomers of methionylmethionine (I) remained
stable throughout the pelleting process and steam treatment
(see table 6).

WO 2010/043558 CA 02740663 2011-04-14
PCT/EP2009/063160
53
Table 6
Sample Feed mixture Feed pellets
Unsupplemented
supplemented with supplemented with
N. feed mixture
Parameter Met-Met (I) Met-Met (I)
CP % 18.64 18.88 18.45
DM % 85.58 86.58
MET % 0.28 0.47 0.51
CYS % 0.32 0.32 0.30
MET+CYS % 0.59 0.79 0.81
LYS % 1.00 0.99 0.98
THR % 0.67 0.70 0.67
ARC % 1.16 1.19 1.17
ILE % 0.75 0.79 0.74
LEO % 1.54 1.60 1.51
VAL % 0.88 0.90 0.85
HIS % 0.47 0.51 0.48
PHE % 0.91 0.92 0.88
GLY % 0.78 0.81 0.77
SER % 0.89 0.94 0.90
ALA % 0.89 0.93 0.89
_
ASP % 1.74 1.75 1.70
GLU % 3.62 3.79 3.58
MET-MET
Ex 0.156 0.153
(I)
MET Ex 0.017 0.022
LYS Ex 0.092 0.104
(Ex: soluble constituents)
In this case, the amino acid determination was based on EU
method 98/64/EC. After extraction of the free amino acids
and methionylmethionine (I), these were subsequently
determined with the aid of an amino acid analyzer by post-
column derivatization with ninhydrin (see table 6).

WO 2010/043558 CA 02740663 2011-04-14
PCT/EP2009/063160
54
The leaching characteristics of the diastereomers of
methionylmethionine (I) from the feed pellets was then
investigated under water. In this case, the dissolving out
of methionylmethionine under water as a function of time,
temperature, water composition (salt or fresh water) was
determined. For this purpose, 20.0 g of the feed pellets
were placed in a close-mesh sieve bag and completely
immersed in 200 g of water in an Erlenmeyer flask. All the
Erlenmeyer flask was subsequently agitated continuously
with a laboratory shaker at a constant temperature of 20 C.
Then, at defined time intervals, a sample of water was
removed in each case and the content of the individual
pairs of methionylmethionine diastereomers in the water was
determined by HPLC (see table 7).
Table 7
Time Methionine MHA MHA-Ca LL/DD-I DL/LD-I LL/DD/LD/DL-I
0 4.0% 6.0% 8.6% 2.7% 0.6% 1.5%
5 12.0% 12.8% 16.5% 3.7% 0.7% 2.0%
10 16.0% 20.8% 28.2% 6.5% 0.9% 3.2%
15 24.0% 28.8% 39.4% 7.7% 0.6% 3.6%
30 39.9% 50.5% 61.7% 12.1% 0.6% 5.4%
60 . 59.9% 75.4% 82.4% 20.6% 1.7% 9.5%
120 79.8% 94.1% 94.1% 27.4% 1.7% 12.3%
210 87.8% 99.9% 97.0% 35.9% 3.8% 17.0%
For comparison, in each case the feed pellets supplemented
with DL-methionine, MHA or calcium MHA were investigated
under the same conditions and thus their leaching
characteristics under water determined under the respective
conditions (see figure 5 and table 7).

Representative Drawing

Sorry, the representative drawing for patent document number 2740663 was not found.

Administrative Status

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Administrative Status , Maintenance Fee  and Payment History  should be consulted.

Administrative Status

Title Date
Forecasted Issue Date 2017-01-17
(86) PCT Filing Date 2009-10-09
(87) PCT Publication Date 2010-04-22
(85) National Entry 2011-04-14
Examination Requested 2014-10-06
(45) Issued 2017-01-17
Deemed Expired 2020-10-09

Abandonment History

There is no abandonment history.

Payment History

Fee Type Anniversary Year Due Date Amount Paid Paid Date
Registration of a document - section 124 $100.00 2011-04-14
Application Fee $400.00 2011-04-14
Maintenance Fee - Application - New Act 2 2011-10-11 $100.00 2011-04-14
Maintenance Fee - Application - New Act 3 2012-10-09 $100.00 2012-09-24
Maintenance Fee - Application - New Act 4 2013-10-09 $100.00 2013-09-26
Maintenance Fee - Application - New Act 5 2014-10-09 $200.00 2014-09-29
Request for Examination $800.00 2014-10-06
Maintenance Fee - Application - New Act 6 2015-10-09 $200.00 2015-09-28
Maintenance Fee - Application - New Act 7 2016-10-11 $200.00 2016-09-22
Final Fee $300.00 2016-12-02
Maintenance Fee - Patent - New Act 8 2017-10-10 $200.00 2017-09-25
Maintenance Fee - Patent - New Act 9 2018-10-09 $200.00 2018-10-01
Maintenance Fee - Patent - New Act 10 2019-10-09 $250.00 2019-09-30
Registration of a document - section 124 2019-12-23 $100.00 2019-12-23
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
EVONIK OPERATIONS GMBH
Past Owners on Record
EVONIK DEGUSSA GMBH
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Cover Page 2011-06-16 1 38
Abstract 2011-04-14 2 82
Claims 2011-04-14 10 319
Drawings 2011-04-14 11 182
Description 2011-04-14 54 1,957
Claims 2011-04-15 14 413
Claims 2016-08-05 9 254
Description 2016-08-05 57 1,997
Cover Page 2016-12-21 1 34
PCT 2011-04-14 33 1,190
Assignment 2011-04-14 5 244
Prosecution-Amendment 2011-04-14 15 443
Prosecution-Amendment 2014-10-06 1 35
Prosecution-Amendment 2015-04-13 2 59
Examiner Requisition 2016-02-08 5 279
Amendment 2016-08-05 23 717
Final Fee 2016-12-02 1 34